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Characterization of malaria sexual stage development in the human host 
 
ABSTRACT 
 
 Due to an increase in malaria control programs in the last decade, the world has 
witnessed dramatic reductions in the number of infections and deaths caused by the malaria 
parasite.  With malaria eradication on the global health agenda, a shift toward transmission-
focused research has led to a renewed focus on a previously neglected stage of malaria: the 
sexual stage (gametocyte).  Malaria’s sexual stages are the only stages in the human host that are 
transmitted to the mosquito vector, and are therefore of critical importance for blocking 
transmission of this devastating disease.  
 The process through which developing gametocytes sequester outside of the bloodstream 
during their 8-10 day maturation is not well understood and stands to be exploited as a potential 
target for therapeutic intervention. In Chapter 1, we discuss the current state of knowledge on the 
development of these stages in the human host.  In Chapter 2, we investigate anatomical 
enrichment sites for developing gametocytes in the human host using autopsy tissue from cases 
of fatal malaria.  Immunohistochemistry (IHC) and quantitative reverse transcriptase PCR-based 
assessments identified the bone marrow as a preferential enrichment site of developing 
gametocytes.  Co-localization with host proteins revealed the enrichment of gametocytes inside 
the extravascular space of the bone marrow, often observed in contact with erythroblastic island 
structures.  In vitro experiments with erythrocyte precursor cells, as well as in vivo co-
!#"
localization studies demonstrated that gametocytes can develop within the cells of the 
hematopoietic system of the bone marrow.  
 In Chapter 3, we present an assay and analysis tool for inferring the presence of young 
and mature asexual and sexual stages in the peripheral blood of infected patients based on gene 
expression data. We apply this assay to malaria patient cohorts and in vitro drug perturbation 
time course experiments, and demonstrate its use in identifying young and mature gametocyte 
carriers, as well as characterizing the effect of a given perturbation on parasite development.  
This body of work aims to contribute to the overall knowledge base for malaria’s elusive 
gametocytes as well as to establish tools for performing future assessments on these 
transmissible stages. 
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CHAPTER ONE:  INTRODUCTION 
 
Toward a Better Understanding of Gametocyte Biology and Epidemiology in 
the Era of Malaria Eradication 
 
1.1 The Malaria Eradication Era and the Shift to Transmission-focused Research 
1.1.1 Global Burden of Plasmodium falciparum Malaria and the Goal of Eradication 
Malaria is a disease with enormous global impact, primarily affecting children in sub-
Saharan Africa. The deadliest parasitic disease of humans, there were an estimated 219 million 
cases of malaria in 2010 resulting in 660,000 deaths [1]. Infection by Plasmodium falciparum, 
the species responsible for the vast majority of these deaths, is characterized by spiking fevers 
and anemia due to the parasite’s replication within and rupture of red blood cells (erythrocytes).  
Approximately 35% of the world’s population lives in areas at risk of transmission with P. 
falciparum [2].P. falciparum is transmitted through a mosquito vector and has a very high 
reproductive index: it is estimated that on average, over 100 secondary cases arise from a single 
case [3].  
Since 2000, due to a worldwide concerted effort to reduce the burden of malaria, deaths 
from this disease have fallen by 33% in the WHO African Region [1].  This reduction was 
achieved through a combination of strategies, including the widespread distribution of 
interventions to block transmission from the mosquito vector (insecticide-treated bed nets and 
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indoor spraying) and to diagnose and treat more cases (rapid diagnostic tests and first line 
antimalarial combination therapies) [1]. In 2007, the Bill and Melinda Gates Foundation 
announced that a major goal of their organization would be to eradicate malaria. The following 
year, the Malaria Eradication Research Agenda (malERA) initiative was designed to define a 
specific set of strategies required to achieve successful eradication of this parasitic disease. This 
is not, however, the first time that malaria eradication has been on the global health agenda.  The 
World Health Organization set out to achieve this goal in the 1950’s and initiated the Global 
Malaria Eradication Program (GMEP).  While the GMEP succeeded in eliminating malaria from 
many regions of the world, in the areas where it failed to eliminate the disease, malaria resurged 
and eliminated gains that had been made through control efforts.  Therefore, in this new era of 
malaria eradiation, the malERA report concluded that eradication is only possible through the 
generation of new tools and knowledge to surmount the vast number of challenges on the road to 
eradication [4]. 
1.1.2 Malaria’s Complex Life Cycle: Challenges and Opportunities for Intervention 
Plasmodium falciparum, the deadliest of the human malaria parasites, has a complex life 
cycle involving growth and replication within two hosts: human and mosquito (See Figure 1.1).  
P. falciparum is transmitted to a human through the infectious bite from a female Anopheles 
mosquito, resulting in the injection of a malaria life cycle stage called the sporozoite.  The motile 
sporozoite homes to the liver, invades a hepatocyte, replicates and produces thousands of 
progeny, termed merozoites, that enter the host’s bloodstream.  In the bloodstream, asexual 
replication begins with merozoite invading an erythrocyte and growing into a young parasite, 
termed “ring” that develops into a larger trophozoite stage and finally a segmented 
multinucleated schizont, which ruptures to release 16-32 progeny.  Asexual replication causes 
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damage to the host’s erythrocytes and vasculature, resulting in fevers, anemia and coma. 
Nevertheless, these stages lack transmission potential, and are therefore a dead end in the 
parasite’s life cycle.  During the rounds of asexual replication within erythrocytes, a parasite may 
diverge down a path toward sexual replication. It has been estimated that on average, one sexual 
stage (termed gametocyte) is produced per 156 asexual stages, thus gametocyte proportion is 
very low in proportion to the total parasitemia [5]. Gametocytes cause no known damage to the 
human host, but are importantly the only stages of the parasite’s life cycle in the human host that 
can be transmitted to the mosquito vector.  After ingestion by a mosquito during a blood meal, 
gametocytes burst out of the human erythrocyte, and the female gametocyte further develops into 
a macrogamete, while the male gametocyte undergoes a process called exflagellation, resulting 
in the productiong of 8 microgametes.  The microgamete penetrates the macrogamete, forming a 
diploid motile zygote (ookinete), which invades the midgut epithelium. The ookinete grows and 
divides as an oocyst, subsequently releasing thousands of sporozoites into the midgut.  The 
sporozoites migrate to the mosquito’s salivary glands, ready to then be injected into the next 
human host during a subsequent blood meal. 
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Figure 1.1. The Life Cycle of Plasmodium falciparum in the human and Anopheles 
mosquito.  Reprinted with permission from [6]. 
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This complex life cycle provides both challenges and opportunities in the pursuit of 
eradication.  Such complexity demands that intervention strategies be varied in their approaches, 
targeting both the human and the mosquito, both the illness and its transmission.  Yet, this 
complexity also offers opportunities for identifying and exploiting weak points in this complex 
life cycle.  Just 10-100 sporozoites need to be injected into the human host in order to result in a 
clinically symptomatic malaria infection. Likewise, just one male and one female gametocyte 
need to be picked up in a blood meal to fulfill the transmission potential of the infection.  These 
gateway stages represent interesting opportunities for interventions aimed at interrupting this 
complex life cycle.  
1.1.3 Shifting Focus: From Morbidity and Mortality to Transmission  
The sexual blood stage of malaria has historically been an understudied area of malaria 
research due to its lack of clinical relevance.  Malaria control programs have traditionally 
focused on reducing morbidity and mortality, and therefore, a main focus of malaria research has 
been on the asexual stage of the disease.  While the asexual stage is associated with the majority 
of the morbidity and mortality of the disease, this stage has no transmission ability.  
The malERA agenda highlights a shift toward blocking transmission and reducing the 
incidence of new infections.  This paradigm shift has placed the gametocyte research as a priority 
area for knowledge and tool development. In particular, the malERA agenda calls for the 
development of new tools targeted at the infectious reservoir of gametocyte carriers, and 
underlines current needs such as a safe and effective drug that kills gametocytes, and a robust 
field diagnostic for infectious gametocyte carriers [7].  
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1.2 Gametocyte Development Within the Human Host: The Path to Successful 
Transmission 
1.2.1 Gametocytogenesis 
Though the pathologic features of malaria - anemia, fevers, and coma - are attributed to 
the asexual-replicating stages, transmission of this disease is caused exclusively by the sexual 
stage, known as the gametocyte. Gametocytes first appear in the peripheral blood approximately 
one week after parasites are first observed in the blood. Sexual development occurs over a time 
frame of 8 to 10 days, four to five times longer than the 48 hour development of asexual stages; 
the lag time before observing gametocytes corresponding to the lag time before the gametocytes 
reach maturity.  As gametocytes develop, they elongate within the host erythrocyte and progress 
through five morphologically identifiable stages. The end result is the formation of a mature 
male or female gametocyte.  Importantly, these mature gametocyte stages are the only stages that 
can be successfully transmitted back to the mosquito vector and continue the parasite life-cycle.  
Prior to their maturity, sexual stages are not present in the peripheral blood [8], suggesting that 
they could sequester in deep tissue during the week-long development.  
1.2.2 Sequestration and Cytoadherence 
A hallmark of Plasmodium falciparum is the adherence of parasitized erythrocytes to 
endothelial cells in the microvasculature, a process referred to as cytoadherence. Sequestration of 
large numbers of infected erythrocytes can result in vessel obstruction, leading to various 
pathologies, most notably coma and death in the case of cerebral malaria. First described in the 
late nineteenth century, cytoadherence offered an explanation for the presence of only young 
asexual “ring” stage parasites and the apparent lack of late asexual trophozoite and schizont 
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parasites in the circulating bloodstream [9].  In the asexual cycle, the process of cytoadherence is 
initiated midway through the cycle, such that the young ring stage is found in the blood 
circulation while the older trophozoite/schizont stages are found in the vasculature of deep 
tissues. Cytoadherence is a parasite adaptation to evade immune clearance: it hinders the body’s 
ability to eliminate infected erythrocytes as it prevents them from being cleared from the 
circulation by the spleen.  In the spleen, erythrocytes infected with older parasites have an 
increased rigidity compared with uninfected erythroytes and are therefore retained and destroyed 
[10].   
A number of autopsy studies have been conducted on cases of fatal malaria to explore the 
distribution of sequestered parasites in the body. A microscopy-based study from postmortem 
samples determined that the highest degree of sequestration (as defined by percent of 
erythrocytes parasitized) was the brain, followed by, the heart, liver, lung, kidney and skin, in 
descending order. All organs surveyed had higher percentages of parasitized erythrocytes –as a 
percent of total erythrocytes—than the peripheral blood. This finding was later confirmed by 
studies in which an abundant parasite protein (Plasmodium lactate dehydrogenase, pLDH) was 
assayed across tissues by enzyme-linked immunosorbent assay (ELISA) on tissue homogenates 
[11], and by immunohistochemistry (IHC) on tissue sections [12].  In the ELISA study, the brain, 
intestine and skin were observed to have the highest levels of pLDH in the tissue homogenates, 
with kidney, liver, intestine and lung also positive for pLDH [11].  And in the IHC study, the 
heart and brain ware observed to have the highest levels of parasitized erythrocytes in tissue 
sections, with detection also observed in the spleen, liver and kidney [12]. In these studies, as 
well as ultrastructural analyses of the brain [13,14] and kidney [15], large numbers of parasites 
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have been observed in contact with endothelial walls, filling the inside of capillaries and venules 
[13]. 
Cytoadherence in asexual parasites is achieved through a complex process of host 
remodeling in which the parasite successfully targets parasite-derived proteins to the surface of 
the host erythrocyte.  PfEMP1 (P. falciparum Erythrocyte Membrane Protein 1) is the major 
parasite ligand involved in cytoadherence and various human endothelial surface proteins, such 
as CD36 and intercellular adhesion molecule 1 (ICAM-1), have been identified as receptors of 
PfEMP1 [16].  PfEMP1 is encoded by a family of about 60 different genes called vars, that are 
variantly expressed, and different PfEMP1 proteins have been shown to exhibit different binding 
properties [17]. The adhesive property of each variant comes from the variable number and 
combination of duffy-binding like (DBL) domains and cysteine-rich interdomain regions (CIDR) 
in the large ectodomain of each of the 60 variants [18].  PfEMP1 expression therefore enables 
sequestration to occur in a tissue-specific manner, due to the differential expression of host 
receptors across tissues that could interact with PfEMP1 variants.  A well characterized example 
is that of placental malaria: the PfEMP1 protein encoded by the gene var2csa has a strong 
affinity for chondroitin sulfate A (CSA), a protein expressed on the endothelium of the placenta 
[19]. 
A number of other proteins are involved in the remodeling of an infected erythrocyte and 
cause a visible transformation of the cell, as seen by electron microscopy, and result from the 
translocation of numerous parasite-derived proteins to the surface of the host cell.  Within the 
cytoplasm of the infected erythrocyte, membrane compartments called Maurer’s Clefts aid in 
trafficking of these proteins to the host cell surface. Electron-dense protrusions, termed knobs, 
emerge on the surface of erythrocytes as the parasite approaches the latter half of its asexual 
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development [20].  Knobs are hypothesized to aid in adherence due to their positive charge; 
which could facilitate the interaction of PfEMP1 and its receptor on this host cell since both host 
cell membranes are negatively charged [21]. In the absence of knobs, adherence is still possible 
via PfEMP1 in static (non-physiological flow) conditions, however this adherence does not occur 
under conditions of physiological flow. The gene encoding KAHRP (knob-associated histidine 
rich protein) has been shown to be required for knob formation, as a genetic knockout resulted in 
loss of knobs [22]. 
1.2.3 Sequestration of the Gametocyte 
Like the asexual trophozoite and schizont stages, immature gametocytes (stages I, II, III, 
and IV) are also absent from the blood circulation and therefore hypothesized to sequester 
through similar mechanisms as the well-characterized process of cytoadherence.  However, 
neither the anatomical localization nor the mechanism of their sequestration is well understood.  
Important distinctions between asexual and sexual development would suggest that sequestration 
may involve different mechanisms in the two pathways.  In the case of asexual development: the 
late asexual trophozoite/schizont stage cytoadheres to a vessel for approximately 24 hours during 
the second half of its development while it replicates its DNA and begins segmenting into 
daughter cells.  These daughter cells then rupture the host erythrocyte to be released as free-
living merozoites that subsequently infect other erythrocytes.  On the contrary, the sexual stage is 
sequestered for the majority of its development and enters the bloodstream while still inside the 
host erythrocyte.  Therefore, an important distinction between these processes is that asexual 
sequestration is an endpoint (ruptured erythrocyte “ghosts” can still be found bound to the 
endothelium, after the progeny merozoites are long gone), while sexual sequestration is 
reversible, resulting in the release of the mature gametocyte at the end of sequestration.  
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Based on early autopsy and biopsy-based studies performed to identify gametocyte 
sequestration sites, another distinction is that gametocytes appear to be enriched in organs in 
which asexual sequestration does not predominate. These early studies found that immature 
gametocytes were enriched in the bone marrow and spleen, as compared with other organs 
[9,23,24]. This work was later revisited in a study in which bone marrow biopsy blood was 
compared with peripheral blood.  This study revealed an enrichment of immature stages in the 
bone marrow, despite asexual parasitemia and mature gametocytemia being constant at both sites 
[25].  Since then, a number of case reports from bone marrow biopsy material have also 
confirmed the presence of immature gametocytes in this organ [26,27], and the absence of 
gametocytes in tissues with large asexual parasite burden, i.e. the placenta [28]. 
Gametocytes have been shown to lack a number of critical components of the well-
described asexual cytoadherence machinery.  Until recently, controversy existed as to whether 
the early gametocyte exhibited different cytoadherence-related properties than the intermediate 
gametocyte.  Early reports suggested that all gametocyte stages lacked knobs [29], while another 
report argued that early gametocytes have knobs but lose them during development [30].  
Similarly, there was no conclusion about the binding ability of gametocytes.  A number of in 
vitro studies have concluded that young gametocytes bind to cells expressing asexual parasite 
receptors (i.e. CD36) at far lower levels than asexual stage parasites [31,32,33], while one study 
concluded that early gametocytes bind at similar levels to asexual parasites [30]. The most likely 
reason for these discrepancies was the lack of molecular tools and approaches for identifying and 
purifying gametocytes, and thus the lack of confidence of truly identifying young gametocytes 
(which are morphologically similar in appearance to asexual stages). Recently, a novel protocol 
for purifying early gametocytes has allowed investigators to revisit this issue [34].  It has now 
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been shown that all gametocytes lack knobs as well as expression of the required knob-
associated histidine rich protein (KAHRP). Additionally, very low expression levels of var genes 
and PfEMP1 protein were found in gametocytes [33,35].  
However, it is still unknown whether gametocytes have the ability to truly cytoadhere.  A 
number of studies have shown little to no binding of gametocytes to CD36 and ICAM-1 
[30,31,33].  Two studies were performed using bone marrow endothelial cells, under the 
hypothesis that gametocytes sequester in the bone marrow, and observed higher levels of 
binding.  Through testing a panel of antibodies to block the binding, the authors identified 
ICAM-1, CD49c, CD166 and CD164 as candidate receptors of gametocyte sequestration in the 
bone marrow [36].  However, these receptors have yet to be confirmed in any subsequent studies.  
A subsequent study that compared binding of stage III-IV gametocytes to three endothelial cell 
lines showed that the highest rate of gametocyte binding was observed in the human bone 
marrow endothelial cell (HMBEC) line, although the rate was still lower than that of asexual 
cells [31]. Both authors note that while gametocytes appear to bind at some low level to bone 
marrow endothelial cells, the binding efficiency observed in these assays is not sufficient to 
explain the depletion of all immature sexual stages from the bloodstream.   
As it appears unlikely that gametocytes utilize the classical method of cytoadherence 
employed by asexual stages, new hypotheses have arisen suggesting that gametocytes could 
employ a mechanical-based method to remain sequestered during development.  As they 
progress through stages I through V, gametocytes undergo a dramatic shift in deformability, 
becoming quite rigid during development (peak stiffness at stage IV), and subsequently very 
deformable upon maturity[37,38,39].  It has been hypothesized that these properties could allow 
the gametocyte to remain stuck and mechanically sequestered in the spleen, and then deform 
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enough to get back into the circulation upon maturity, when the gametocyte needs to be picked 
up by a mosquito to continue the cycle.  Mathematical modeling has demonstrated that based on 
their dimensions and deformability characteristics, this hypothesis is theoretically possible [38], 
however, it remains to be observed in vivo.  
Many questions remain in the pursuit of understanding gametocyte sequestration: i) 
where exactly do immature gametocytes reside in the human host while they develop?, ii) why 
do they sequester in distinct anatomical niches compared to asexual parasites?, iii) through what 
mechanism are gametocytes staying sequestered from the bloodstream during their development, 
finally, iv) through what mechanism do they return to the blood stream after maturation?   
1.2.4 Significance of Understanding Gametocyte Development in the Era of Malaria 
Eradication  
Elucidating uncharacterized processes in gametocyte development may unveil new 
targets for therapeutic intervention. Drugs that effectively kill gametocytes are predicted to have 
the best impact in reducing new cases of malaria in low transmission settings, where infections 
occur more rarely population-wide and thus prevention of each new infection is critical [40]. 
Thus, as the number of malaria cases continues to fall, a drug that effectively kills gametocytes 
will be an important tool for malaria eradication.  
Drugs that target the gametocyte are lacking as this has historically been a neglected area 
for malaria drug development efforts as most drugs are designed to cure disease symptoms, not 
necessarily to prevent transmission.  Artemesinin (the primary component of most first line 
antimalarials employed globally for P. falciparum) and its derivatives have been shown to be 
ineffective in killing mature gametocytes in vitro [41,42] and 5-39% of artemesinin-treated 
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individuals have been found to carry gametocytes one month after completing their treatment 
course [43,44].  The only currently licensed antimalarial drug with clear efficacy against 
gametocytes is primaquine [45], however, this drug has been linked to a dangerous side effect in 
individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency, a blood condition most 
common in parts of the world with a high malaria burden [46].  
 
1.3 Gametocyte Detection: Understanding the Infectious Reservoir 
1.3.1 Gametocyte Detection 
 In order for malaria to be transmitted to the mosquito vector, a mosquito must ingest at 
least one male and one female gametocyte from a blood meal. Therefore, the presence of mature 
gametocytes in the peripheral blood has historically been used as an indication of an individual’s 
potential infectiousness.  The standard method for detecting gametocytes is the identification of 
crescent-shaped mature gametocytes in a thick smear examination; however, this approach is 
limited by its low sensitivity.  As low as 1-10 gametocytes per uL of blood can lead to infection, 
and thick smear sensitivity is only in the range of 10-100 gametocytes per uL thus missing 
individuals with low level gametocyte burden [47]. To increase sensitivity of gametocyte 
detection, transcriptional approaches such as reverse transcriptase PCR (RT-PCR), quantitative 
nucleic acid sequence based amplification (QT-NASBA) and reverse transcription loop-mediated 
isothermal amplification (RT-LAMP) have been developed for gametocyte detection using 
established molecular markers of gametocyte development [48,49,50].  
Molecular methods for detecting gametocytes have been shown to be 100-1000 times 
more sensitive than thick smear [47,51], and thus have painted a very different picture of 
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gametocyte carriage than what was previously established based on microscopy alone.  
Population surveys using the mature gametocyte marker Pfs25 in QT-NASBA have shown that 
between 15-70% of cross-sectional endemic area study cohorts [48,52,53] and 39-89% of 
uncomplicated malaria cohorts are Pfs25-positive [51,54,55,56,57,58], revealing a much larger 
reservoir of submicroscopic gametocyte carriers than previously hypothesized.  
1.3.2 The Infectious Reservoir 
While children under five years of age in endemic settings account for the majority of 
malaria infections, and suffer the greatest morbidity and mortality of the disease [1], the adult 
population remains an important factor in the context of the epidemiology of gametocyte 
carriage.  A collection of cross-sectional surveys of gametocyte carriage in Burkina Faso 
revealed that an individual’s gametocyte proportion increases with the age of the host. By 
microscopy, it was estimated that 1.8% of parasites in the bloodstream of young children are 
gametocytes versus 18.2% in adults, a striking difference also confirmed by QT-NASBA [59].  
This study confirmed earlier data from endemic settings in Tanzania and the Gambia suggesting 
that adults contribute substantially to the infectious reservoir [60].  These studies measured the 
rate of infectious gametocyte carriers in each age group, and adjusting by the population age 
structure, concluded that between 28-38% of all transmission in these endemic settings comes 
from adults. Further, there is a temporal dynamic to gametocyte carriage over the course of one’s 
infection.  Certain physiological factors are believed to induce a higher fraction of parasites to 
diverge and proceed down a path of sexual development and therefore increase infectiousness 
[61].  Anemia and long illness duration were found to be associated with higher gametocyte 
carriage in a cohort of patients from Thailand [62].  
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1.3.3 Significance of Improving Gametocyte Detection in the Era of Malaria Eradication   
Molecular methods have made it feasible to detect gametocytes within the entire range 
that is believed to be biologically relevant for infectivity.  Interestingly, these methods have 
revealed that a much larger fraction of infected individuals harbor gametocytes than previously 
thought.  If in fact all infections harbor gametocytes to some degree, then there is a need for 
more sophisticated assays to characterize these gametocytes. Although mature gametocytes are 
required for infectivity, mosquito feeding studies have shown that there is a weak correlation 
between gametocyte density and infectivity, and an elevated level of gametocytes does not 
necessarily always translate to higher levels of infectivity [63]. Therefore, studies are required to 
determine what factors separate infectious gametocytes from non-infectious gametocytes and 
whether there are better markers for infectivity.  New molecular tools could be used to identify 
individuals who are infectious (which could depend on age of gametocyte, sex ratio of 
gametocytes, or other marker of health of gametocytes) or who carry the young gametocyte ring 
stage, which is hypothesized to circulate in the peripheral blood for a short time (less than 24 
hours) prior to sequestration [25]. This young gametocyte could potentially serve as an early 
biomarker for conversion to sexual development. Such a tool would be of great aid in 
understanding triggers of gametocytogenesis in vivo.  
 The previous malaria eradication program lacked molecular methods for careful 
monitoring of gametocyte carriage, however real-time monitoring of gametocyte carriage and 
infectivity is important in pre-elimination settings.  Malaria is a dynamic ecological system and 
therefore when its population size is reduced, there may be selection for highly infectious strains. 
There is some evidence to suggest resurgences are in part due to selection for high gametocyte-
producing strains [64].  In a resurgence that occurred in 1960 in Indonesia where control 
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programs had reduced but not eliminated malaria, an increased number of gametocyte carriers 
was noted [65].  And in 1980, over the course of the Garki Project (a malaria control study 
carried out in Northern Nigeria) gametocyte carriage among 9-28 year olds showed a significant 
increase compared to that of the same age group in a control village with no intervention in the 
same time frame [66].  
 
1.4 Summary of Aims 
 This dissertation aims to contribute to the field’s basic knowledge of gametocyte biology 
as well as to provide tools for detecting gametocytes.  Thus, the first aim is to characterize the 
process of gametocyte sequestration as there has yet to be a comprehensive study on this topic in 
the human host using molecular approaches. Using samples from autopsy cases of fatal pediatic 
malaria in Malawi, we employ a combination of immunohistochemistry (IHC) and qRT-PCR to 
identify enrichment sites of immature gametocytes in the human host.  Further, we characterize 
tissue-specific patterns of gametocyte sequestration using IHC to co-localize gametocytes with 
host proteins.  Finally, we use electron microscopy to examine the ultrastructure of sequestering 
gametocytes.  
 In the second aim, we develop a framework and assay for identifying young, intermediate 
and mature gametocytes from within a mixed population of parasites. At any point during 
infection with P. falciparum, a peripheral blood sample is likely to contain a mixture of asexual 
and sexual stages. We re-analyze existing microarray data to identify stage-specific signatures 
within a mixed stage population.  We then use these signatures to define a small set of sentinel 
genes that could be used to infer the stage composition of a sample. Finally, we apply the system 
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to identify carriers of young and mature gametocytes in cohorts of severe and uncomplicated 
malaria patients. 
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Abstract 
In the current study, we systematically quantified gametocyte sequestration in autopsy cases 
from an ongoing study of fatal pediatric malaria in Blantyre, Malawi.  We performed an organ 
survey using immunohistochemistry (IHC) on tissue sections from nine body sites (brain, lung, 
heart, intestine, liver, kidney, subcutaneous fat, spleen, and bone marrow), which suggested an 
enrichment of gametocytes in the bone marrow. Quantitative RT-PCR supported this finding and 
confirmed the presence of young developing gametocytes in this organ. Expanding our survey to 
thirty patients, we performed double-labeling of parasite and host markers to sub-localize 
gametocytes within this organ.  We observed gametocytes enriched in the extravascular space of 
the bone marrow; frequently co-localized with erythroblastic islands. We show that gametocytes 
are infrequently found within bone marrow macrophages, and that by electron microscopy, we 
observed that a subset of parasitized cells in the bone marrow appear knobless, both in agreement 
with recent studies suggesting that gametocytes do not alter the surface of the host erythrocyte as 
is observed with asexual stages. Finally, we show both in vivo and in vitro, using a model system 
of erythropoietic development, that gametocyte development can occur within erythrocyte 
precursor cells (orthochromatic erythroblasts and reticulocytes). Understanding the process 
through which P. falciparum gametocytes sequester outside of the bloodstream during 
development is of critical importance, considering the field!s renewed focus on understanding 
the dynamics of malaria transmission and the development of new strategies to interrupt it. 
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Introduction 
Sequestration of asexual stage infected red blood cells is a major means of severe pathogenesis 
in falciparum malaria [67], but it is not known to what degree gametocytes share mechanisms of 
sequestration. The mechanisms of tissue-specific sequestration of asexual stages have been 
studied in great detail and revealed the molecular processes of host cell manipulation and 
subversion by the parasite [68,69,70]. Despite the importance of sequestration for survival 
during the long period of sexual development, little is known about the underlying molecular 
mechanisms and sites of tissue sequestration for these stages. In autopsy case studies performed 
in the 1930’s [23], gametocytes were observed in the bone marrow and the spleen. This early 
work was revisited through the study of bone marrow biopsy samples, which also revealed the 
presence of immature gametocytes in that organ [24,25,26]. Many attempts have been made to 
demonstrate in vitro binding of gametocytes to endothelial cells or purified receptors, and 
expression of known asexual parasite cytoadherence ligands in developing gametocytes. These 
studies have shown low levels of both binding [30,31,32,36,71] and parasite adhesion ligand 
expression [33], and thus it has been suggested that different receptors and/or a novel 
mechanism could be involved in the sequestration of developing gametocytes, distinct from the 
well-described binding interaction of asexual stages [26,33,72]. In support of this hypothesis it 
has recently been shown in P. falciparum that gametocyte sequestration dynamics coincide with 
alterations in gametocyte rigidity, suggesting that some form of mechanical sequestration may 
be possible [38,39]. Here we present the results of a systematic organ survey, using the largest 
existing collection of autopsy cases in fatal malaria [73], to identify and characterize gametocyte 
sequestration sites.  
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Materials and methods 
Autopsy cohort 
The institutional review boards (IRB) at the University of Malawi College of Medicine, 
Michigan State University, and the Harvard School of Public Health approved all aspects of 
autopsy cohort study and the severe malaria peripheral blood cohort study.  Informed written 
consent was obtained from all parents/guardians of the enrolled patients.  IRB at the Brigham 
and Women’s Hospital approved the use of discarded surgical tissue for laboratory experiments. 
 
Autopsy cohort 
The autopsies analyzed in this study are part of a pediatric severe malaria and postmortem 
autopsy study that was performed between 1996 and 2011 [73]. Children meeting the clinical 
case definition of cerebral malaria (CM) were admitted to the Malaria Research Ward, located in 
the Queen Elizabeth Central Hospital in Blantyre, Malawi and enrolled in the severe malaria 
study upon the consent of the parent or guardian. Criteria used for diagnosis and clinical 
management have been previously described [73].  Over 3000 individuals were enrolled in the 
study over this time period.  The mortality rate for the study participants is between 15-20%.  
Consent was given to conduct an autopsy for 103 cases, and these autopsies were performed 
between 2 and 14 hours after death.  
 Tissue specimens were collected in various formats at the time of autopsy. Specimens 
were stored in 10% buffered formalin to be later used for histological examination and 
immunohistochemistry analysis.  Storage in glutaraldehyde buffer enabled specimens to be 
processed for electron microscopy. RNAlater snap frozen samples were later used for qRT-PCR 
analysis.  
%&"
Severe malaria peripheral blood cohort 
The peripheral blood samples analyzed in this study are part of a severe malaria study, using an 
entire seasonal cohort from January to June of 2010 [73]. Seventy-six children were enrolled that 
season, with the consent of the parent or guardian.   Three milliliters (mL) of venous blood was 
collected at time of admission in Tri-Reagent BD, shaken for 1 minute, and then frozen and 
stored at "80°C.  A portion of this 3mL sample was used for qRT-PCR analysis. 
 
Plasmodium falciparum in vitro culture 
Parasites of the P. falciparum reference strain 3D7 and Pf2004 were used for this study. Parasites 
were maintained in fresh type O+ human erythrocytes (Research Blood Components, LCC) at 
2% hematocrit in HEPES-buffered RPMI 1640 containing 1% (w/v) AlbuMAX II (Invitrogen), 
0.5 ml Gentamycin, 2.01 g sodium bicarbonate and 0.05 g Hypoxanthine at pH 6.74. Cultures 
were kept in a controlled environment at 37°C in a gassed chamber at 5% CO2 and 1% O2. For 
gametocyte production for qRT-PCR marker testing, gametocytogenesis was triggered using the 
3D7 parasite line.  Sorbitol synchronized ring-stage parasites were seeded at 1-2% parasitemia 
into 75cm2 vented flasks at 6% hematocrit. Gametocytogenesis was then triggered according to 
the Fivelman protocol [74]. Briefly, asexual parasites were grown to a high parasitemia in the 
presence of partially spent (“conditioned”) medium, and then sub-cultured at the schizont stage 
into new dishes containing fresh media and erythrocytes. 
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Controls for immunohistochemistry  
To determine antibody specificity in the tissues of interest, we generated formalin-fixed and 
paraffin-embedded tissue samples containing erythrocytes infected with asexual and sexual 
parasites stages. Briefly, 100 µl of packed erythrocytes, derived either from asexual cultures or 
from individual time points of gametocyte development time courses, were mixed with thrombin 
and fetal bovine plasma, wrapped in lens paper and fixed with formalin. Cell clots were then 
placed into a paraffin wax block together with a composite of surgical tissues obtained from the 
Brigham Hospital from the same 9 organs that are analyzed in the autopsy study, and sliced at 3 
µm. Using these samples, pLDH antibodies were titrated for parasite-specific labeling and Pfs16 
antibodies both for parasite- and gametocyte-specific labeling by IHC, with tissue samples 
allowing for antibody titration against tissue-specific background (Appendix Figure A3).  
 
Immunohistochemistry assays 
Formalin-fixed paraffin-embedded tissues and control blocks were cut into 3 micron sections and 
mounted on slides.  Sections were dried overnight at 37°C, deparaffinized in xylene, and 
hydrated through a series of graded alcohols, finishing in water.  Antigen retrieval was 
performed by incubating slides at approximately 95°C in a steamer for 20 minutes.  One of two 
antigen retrieval solutions was used for this process (as determined based on antibody 
optimization conditions): 1 mM EDTA + 0.05% Tween at pH 8 or Retrieve-All-2 antigen 
retrieval buffer pH 10 (Covance Research Product, Dedham, MA).  EDTA solution was used for 
the initial pLDH and Pfs16 screen, as well as for the double-labeling of pLDH and Pfs16 with 
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PECAM-1.  For the double-labeling of parasite antibodies with CD163 and CD71/Transferrin 
Receptor, Retrieve-All-2 buffer was used.  Following antigen retrieval, slides were blocked using 
a universal blocking buffer (Thermo Scientific) for 20 minutes, followed by 10 minutes each of 
avidin and biotin blocking steps to block endogenous biotin and avidin, respectively.  Antibody 
incubation was then performed for either 2 hours (PECAM-1) or 1 hour (all other antibodies), 
and each antibody was diluted in blocking buffer.  Wash steps, in between each step therafter 
were performed with TBS + 5% Tween for 3 x 5 minutes.   
 For the initial screen, secondary anti-mouse biotinylated antibodies were used, followed 
by streptavidin conjugated to alkaline phosphotase (AP).  For the development of signal, 
naphthol phosphotase-fast red chromagen reagent was applied.  Slides were subsequently rinsed 
in water and counterstained in Mayer’s hematoxylin, and mounted in aqueous mounting medium.  
Slides were blinded to patient ID and independently counted by two microscopists, counting 
parasites in 100 consecutive high power fields, starting in the upper left corner of each section. 
The average of the microscopists’ counts were used for the analysis.   
 For double labeling with platelet endothelial cell adhesion molecule (PECAM-1), a 
sequential double staining protocol was used, as previously described [75], as both antibodies 
were raised in the same host.  Here, primary human host antibody (mouse anti-PECAM-1) was 
incubated for 1 hour, followed by a peroxidase block (to block endogenous peroxidase activity), 
secondary anti-mouse biotinylated antibody, streptavidin conjugated to horse radish peroxidase 
(HRP) and development of signal with 3,3’-Diaminobenzidine (DAB) chromagen reagent.  After 
washing in TBS, blocking steps with avidin and biotin were repeated (to block residual unbound 
biotin or streptavidin from first reaction).  The parasite antibody (mouse anti-pLDH or mouse 
anti-Pfs16) was incubated for 1 hour, followed by a secondary anti-mouse biotinylated antibody, 
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streptavidin conjugated to alkaline phosphotase (AP), and development of signal with naphthol 
phosphotase-fast red chromagen reagent. Slides were subsequently rinsed in water and 
counterstained in Mayer’s hematoxylin, and mounted in aqueous mounting medium.    
 For the CD163 and CD71 double labeling experiments, we used a double-staining 
protocol for mouse-rabbit combinations, as described in [75].  Here, a primary antibody for a 
human host protein (either rabbit anti-CD163 or rabbit anti-CD71) and a parasite protein (rabbit 
anti-BIP or rabbit anti-Pfs16) were incubated simultaneously.  This was followed by a 
peroxidase blocking step, and the addition of secondary antibodies (biotinylated goat anti-rabbit 
and HRP-conjugated goat anti-mouse), followed by streptavidin conjugated to alkaline 
phosphotase (AP).  The HRP was developed by a brief incubation with 3,3’,5,5’-
Tetramethlybenzidine (TMB) substrate and washed with TBS. The AP was then developed by 
incubation with naphthol phosphotase-fast red chromagen reagent. Slides were subsequently 
rinsed in water and mounted in aqueous mounting medium. 
 
Parasite and host marker antibodies  
Working concentrations for each antibody were determined using the control samples as 
described above.  The initial screen was performed using antibodies targeting pLDH, 
Plasmodium lactate dehydrogenase, which is constitutively expressed in parasites and previously 
identified as a useful marker of malaria parasites in autopsy tissue [12], and Pfs16, a gametocyte 
antigen expressed throughout the duration of gametocyte development [76].  Here we used a 
mouse monoclonal anti-pLDH antibody (kind gift from Dr. Michael Makler, Flow, Portland, 
OR) at 1:750 and a mouse polyclonal anti-Pfs16 antibody (provided by Dr. Kim Williamson, 
Loyola University) at 1:5000.  The co-localization screen with platelet endothelial cell adhesion 
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molecule (PECAM-1), a marker of humam endothelial cells, was performed with these same 
parasite antibodies as well as a mouse anti-PECAM-1 antibody (Clone JC70A, Dako) at 1:1000.  
The co-localization of parasite proteins with CD163, a marker of macrophages, and CD71, 
expressed on erythroblasts and reticulocytes, was performed using Pfs16 and BIP, a heat shock 
protein expressed in all blood stages.  In this case, due to the need to co-localize parasites within 
host cells, we optimized protocols for rabbit parasite antibodies and human host mouse 
antibodies to minimize cross-reactivity.  We generated a rabbit anti-Pfs16 antibody against a 
peptide of Pfs16 for this purpose. This rabbit Pfs16 antibody was used at 1:4000 and the rabbit 
anti-BIP antibody (provided by MR4, clone MRA19) was used at 1:750.  Host proteins were 
labeled using mouse anti-CD163 (Leica, clone 10D6) at 1:25 and mouse anti-CD71 (Invitrogen, 
clone H68.4) at 1:1000.   
 
Autopsy tissues used in each analysis 
 For the initial screen, we first performed IHC using platelet endothelial cell adhesion 
molecule (PECAM-1), a marker of host endothelial vessels on bone marrow tissue from the 21 
most recent autopsy cases. This was done as a quality control measure for our subsequent tissue 
analysis.  Of those 21, PECAM-1 labeling failed in 3 individuals, which we then excluded from 
further analysis.  Among these 3 excluded individuals were the 2 individuals with the longest 
post-mortem intervals (over 12 hours in length).  We also excluded HIV positive patients from 
our analysis because the effect of HIV on the natural progression of malaria infection is not well 
understood [27]. This excluded 8 additional patients. This left us with ten HIV-negative, 
PECAM-1-positive autopsy cases for which we performed our organ screen.  These cases had 
post-mortem intervals ranging from 4 to 12 hours.  
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 For the subsequent characterization of parasites intra- and extravascularly using double 
labeling with PECAM-1, we expand our cohort.  From the remaining 82 cases in the autopsy 
study that we did not use for the initial organ screen, we identified a subset of 28 patients based 
on applying the following filters: (a) HIV-negative status, (b) post-mortem interval under 9 
hours, and (c) availability of bone marrow FFPE block. Six of these cases were subsequently 
excluded from further analysis due to the lack of PECAM-1 staining.  For the remaining 22 bone 
marrows, 20 had pLDH-positive parasites and 16 had Pfs16-positive parasites.  These 22 in 
addition to the 8 cases from the initial screen in which gametocytes were found in the bone 
marrow gave us a total of 30 patients upon which to examine intra- and extravascular bone 
marrow parasite localization.  
 For the co-localization of parasite markers with CD163 and CD71, we used the 22 bone 
marrows in which at least 5 pLDH-labeled parasites were detected in 50 high power fields in the 
previous screen. For these 22, we applied double-labeling of both CD163 and CD71.  All 22 
labeled successfully with CD163 and CD71.  For the co-localization of Pfs16 with CD71, data is 
plotted for only the 8 patients in which at least 5 Pfs16-labeled parasites were detected in 50 high 
power fields.  
 
Size Measurements with ImageJ 
Images of parasites within control in vitro blocks and human autopsy tissue were taken using a 
digital microscopy camera (Zeiss AxioCam IC).  These images were processed using ImageJ 
software. In ImageJ, a threshold was applied to each image to create masks of each positively-
labeled cell in a binary black and white format. The Analyze Particles feature was subsequently 
applied to each mask, and measurements of area, diameter, perimeter and circularity in microns 
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were recorded for each particle.  
 
Immunofluoresence 
For the evaluation of quantitative PCR markers and for localization of gametocytes in 
erythrocyte precursor cells, immunofluoresence assays were performed with cell monolayers on 
glass slides, prepared as described previously [77]. For the purpose of evaluating PCR markers, 
slides were fixed in ice-cold methanol, blocked with 5% nonfat dry milk powder, incubated with 
polyclonal mouse antibody against Pfs16 (1:2500) [78], washed and incubated with a secondary 
antibody conjugated to Alexa 488. Parasite nuclei were labeled with DAPI and quantification 
was done on the proportion of FITC(+) parasites out of the total number of DAPI(+) parasites.  
For erythrocyte precursor cell localization, slides were fixed with 4% paraformaldehyde and 
0.0075% glutaraldehyde. Slides were subsequently washed in PBS and incubated for 10 min 
with wheat germ agglutinin (WGA) directly conjugated to Alexa 488 (8 #g/mL, Invitrogen). 
After washing, cells were permeabilized with 0.1% Triton X-100 in PBS for 10 min, blocked 
with 3% skim milk in PBS for 30 min, and incubated with rabbit anti-Pfs16 (1:40,000) for 1h. 
Slides were washed and primary antibodies detected by incubation for 1h with Alexa-594-
conjugated anti-rabbit IgG (1:500, Invitrogen). All WGA and antibody dilutions were made in 
PBS supplemented with 3% bovine serum albumin. To avoid photobleaching, cells were 
mounted with Vectashield (Vector Laboratories) containing 1.5 mg/mL DAPI to stain for DNA. 
All incubations were performed at room temperature in a humid chamber. 
 
Transmission Electron Microscopy 
Transmission Electron Microscopy (EM) was performed on the bone marrow and brain from one 
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patient for which we had well-preserved tissue for EM, and both parasites and gametocytes were 
identified in the patient’s brain and bone marrow during the initial IHC screen.  Tissue taken at 
autopsy was fixed in 2% glutaraldehyde.  Samples were then post-fixed in osmium tetroxide, 
dehydrated in ethanol, treated with prophylene oxide and emdedded in Epon-Araldite.  Thin 
sections were stained with 1% toluidine blue and examined under light microscopy to identify 
sections of the tissue that contained parasites.  Ultra-thin sections were then made and stained 
with uranyl acetate and lead citrate just prior to imaging.  Bone marrow sections were imaged 
using a Tecnai G2 Spirit BioTWIN conventional electron microscope.  Brain sections were 
imaged using a JEOL 1200EX- 80kV conventional electron microscope.  
 
RNA Extraction, DNAse Digest and Reverse Transcription.  
Tissue sections stored in RNALater were processed through either grinding in liquid nitrogen 
using a mortar and pestle or homogenizing in TriReagent BD (Molecular Research Center). All 
TriReagent BD samples were then processed as previously described [79]. Briefly, RNA was 
extracted by the phenol-chloroform method followed by DNAse digest (Ambion), and a second 
phenol-chloroform extraction for protein removal and sample concentration. First strand cDNA 
synthesis was performed using the SuperScript III First Strand Synthesis kit (Invitrogen). 
 
qRT-PCR assay 
To develop a qRT-PCR assay capable of differentiating between developmental gametocyte 
stages, we selected three established markers with peak times during early (PF14_0748), mid 
(Pf4845) and late (Pfs25) gametocyte development, respectively. To establish stage-specificity a 
series of in vitro gametocyte time courses were performed using the protocol according to 
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Fivelman et al [74], and samples were collected daily during asexual growth and subsequent 
gametocyte development. In addition, we determined the sensitivity of each primer pair in 
dilution curves using plasmids containing the cloned target fragments as template. These 
experiments demonstrated a detection limit ranging between 101 – 102 copies for each primer 
pair. All primer pairs were shown to be not cross-reactive with human cells using cDNA from 
human C32 cells. 
 
qRT-PCR conditions  
Quantitative PCR was performed on cDNA in 20 uL reaction volumes in either an ABI 7300 or 
Viaa7 machine (both, Applied Biosystems).  Amplification was performed using iQ SYBR 
Green Master Mix (BioRad), and primers for each of the genes of interest at 250nM 
concentration.  Reaction conditions were as follows: 1 cycle x 10 min at 95°C and 40 cycles x 30 
sec at 95°C and 1 min at 58°C.  Each cDNA sample was run in triplicate, and each plate 
contained a dilution series of cDNA amplicons cloned into pGEM plasmids. As a positive 
control to ensure parasite RNA was present in our samples, we used primer pairs for P. 
falciparum ubiquitin conjugating enzyme transcript as a constitutively expressed parasite marker 
as described previously [80]. 
 
Erythrocyte precursor cell culture  
CD34+ hematopoietic stem cells isolated from a single donor were purchased commercially. 
Cells were co-incubated on a stromal cell monolayer. On day 19 of culture, cultured red blood 
cells (cRBCs) were collected for parasite growth assays (41% of the cRBC were nucleated and 
59% were enucleated, and of the latter 95% were reticulocytes and 5% were normocytes as 
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determined by New Methylene Blue staining). Parasites of the strain Pf2004 were sorbitol-
synchronized at the ring stage.  They were then induced to form gametocytes as described 
previously [74] until reaching the late trophozoite/schizont-stage. At this point, infected 
erythrocytes were enriched by magnetic cell sorting (MACS), which yielded a parasitemia of 
92%. Parasites were plated with cRBCs in triplicates at a final parasitemia of 1.1% and 0.7% 
hematocrit in 100 #L RPMI supplemented with 10% human AB+ serum. Following reinvasion, 
cells were collected by cytospin and stained with Giemsa to monitor parasite growth. Media was 
changed daily until day 4. On day 1 and 4, cells were collected by cytospin onto poly-L-lysine 
coated slides for immunofluorescence microscopy assays (IFA), and slides were air-dried and 
stored desiccated at -20°C. 
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Results 
Organ Survey to Determine Enrichment Sites of Immature Gametocytes. 
Immunohistochemistry-based organ survey.  We applied an immunohistochemistry-based 
labeling approach to autopsy tissue sections from cases of clinically diagnosed cerebral malaria. 
P. falciparum lactate dehydrogenase (pLDH) was used to label all parasites [12] and the 
gametocyte antigen Pfs16 [78] to label all gametocytes. In the initial screen, we surveyed tissue 
from eight organs plus subcutaneous fat from a total of six autopsy cases. This screen revealed 
the highest levels of gametocytes in the spleen, brain and bone marrow (Figure 2.1A/B and 
Appendix Figure A1). To further investigate gametocyte loads in the three candidate organs we 
included samples from 4 additional patients.  In this 10 patient cohort, 8 had detectable 
gametocytes in at least one tissue. The spleen, brain, heart and gut revealed the highest total 
parasite densities (Figure 2.1B), which is consistent with previous studies showing high levels 
of asexual parasite sequestration in these organs [11,13,81]. To normalize differences in total 
parasitemia due to the heterogeneity in vascularity between tissues, we assessed gametocyte 
enrichment as the number of Pfs16-positive cells divided by the number of pLDH-positive cells 
in 100 high power fields (HPF) for each sample. The only organ with a mean gametocyte 
proportion greater than 50% was the bone marrow (Figure 2.1C). All other organs had a mean 
gametocyte fraction under 25%, and all but spleen were under 13%, which is consistent with 
previously reported low percentages of circulating gametocytes in human malaria infection [63].  
Quantitative PCR-based assessment of gametocyte age across tissues.  To determine whether 
the bone marrow is enriched for the early and intermediate stages of gametocyte development 
that are known to occur outside of blood circulation, we measured the tissue-specific expression 
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of three genes that have peak expression at different points throughout gametocyte development. 
Based on microarray evidence and previous validation in the literature [82,83], as well as our 
own in vitro qRT-PCR time course experiments (Appendix Figure A2), we selected the PHISTa 
gene PF14_0748 as a marker of young gametocytes, transmission-blocking antigen precursor 
Pfs4845 for intermediate gametocytes, and ookinete surface antigen precursor Pfs25 for late 
developing and mature gametocytes. As we were interested in whether there was an enrichment 
of young gametocytes in any organ, relative to what is found in the peripheral blood, we aimed 
to look at gene expression relative to that found in peripheral blood. We were unable to collect 
peripheral blood from these autopsies, so we instead analyzed peripheral blood from an entire 
seasonal cohort of severe malaria patients, who were enrolled in the severe malaria same study as 
the autopsy cases (N= 78). Taking the mean expression level of these three markers across the 
peripheral blood samples, we determined the fold change enrichment of each gametocyte marker 
in each organ. This analysis revealed that the expression of the young and intermediate 
gametocyte markers PF14_0748 and Pfs4845 peaked in the bone marrow, while expression of 
the mature gametocyte marker Pfs25 was distributed across several organs, including the spleen, 
heart and bone marrow with low level expression in the brain (Figure 2.1D). 
Size-based assessment of gametocyte age across tissues.  To further assess age of gametocytes 
across organs, we measured the size of Pfs16-labeled gametocytes from the 2 tissues with the 
highest gametocyte fraction (spleen and bone marrow).  For this assessment, we used tissues 
where we could detect at least 15 gametocytes, resulting in 3 spleen and 5 bone marrow sections 
to use for this analysis, from a total of 5 patients (Figure 2.1E).  We performed size 
measurements using ImageJ on in vitro gametocytes of known stage stored and prepared in the 
same way as the autopsy tissue sections. In each of the five bone marrows examined, 
&("
gametocytes were very rarely of a size corresponding to a stage IV-V gametocyte, while in the 
spleen, large gametocytes were far more common (Figure 2.1E). Generally bone marrow-
residing gametocytes across patients are observed to fall within a tight size range, corresponding 
to stage I, II and III gametocytes from our control in vitro blocks. This further illustrates a 
specific enrichment of young gametocytes in the bone marrow.  
 
 
&)"
Figure 2.1. Enrichment of developing gametocytes in the human bone marrow. (A). 
Representative images of Pfs16-labeled gametocytes and pLDH-labeled parasites in bone 
marrow, spleen and brain. Parasite antigens are visualized with alkaline phosphatase (AP) 
FastRed chromogen and nuclei are labeled with hematoxylin blue stain. The panel shows large 
gametocytes in the spleen and brain, as well as smaller gametocyte in the bone marrow. Shown 
are also multiple large pLDH-labeled trophozoite or schizont stage parasites sequestered in a 
brain capillary. A complete set of representative images of labeled parasites from all tissues is 
shown in Appendix Figure A1. In the spleen, free hemazoin can be observed.  In the bone 
marrow, parasite appears in context with nucleated cells of the hematopoietic system.  In the 
brain, Pfs16 labels a subset of parasites within capillaries while pLDH labels all parasites. Hz: 
free hemozoin. hp: hematopoietic cells of the bone marrow. iRBC: unlabeled infected RBC. cap: 
capillary in the brain. gm: gray matter in the brain. (B). Quantification of parasite and 
gametocyte load across tissues. Numbers of pLDH-positive (left axis) and Pfs16-positive cells 
(right axis) were quantified per 100 high power fields (HPF) for each tissue. For bone marrow, 
spleen and brain samples from 10 patients were analyzed, and for the remaining tissues samples 
from 6 patients were analyzed. The observed distribution confirms previous studies with highest 
parasite loads in spleen, brain, heart and gut. (C). Comparison of gametocyte fractions across 
tissues. Fractions are calculated as ratio of Pfs16-positive cells to pLDH-positive cells in 100 
high power fields from each sample, for each tissue in which at least 10 pLDH parasites were 
observed. This approach normalizes out the variability in total parasite load across patients and 
demonstrates highest enrichment of gametocytes in the bone marrow, with a mean fraction of > 
60% across 10 patients.  
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Figure 2.1 (Continued). (D). qRT-PCR analysis to quantify gametocyte stage distribution 
across tissues. Markers for early developing (Stage I/II, PF14_0748), mid developing (Stage 
III/IV, Pfs4845), and late developing and mature gametocytes (Stage IV/V, Pfs25) were used for 
gametocyte quantification. RNA from each of the nine tissues from 5 patients were analyzed, as 
well as RNA from the peripheral blood of 78 patients enrolled during one season of the severe 
malaria study were analyzed. The data are shown as relative gene expression (fold increase) of 
each of the 3 gametocyte genes relative to the mean levels of those genes across the 78 
peripheral blood samples. (E). Size distribution of gametocytes across organs and patients. 
Size distribution for tissues with 10 or more gametocytes per 100 HPF from the initial screen. 
Measurements of area in square microns with made using ImageJ software, applied to Pfs16-
labeled IHC images from the initial screen. 15-20 gametocytes were measured for each tissue, 
and are plotted with different symbols for different patients (a total of 5 bone marrow and 3 
spleens across 5 patients are shown). In vitro gametocytes were generated and measured for 
comparison to known gametocyte stages (See Appendix Figure A3). Gametocytes found in the 
bone marrow are smaller in area, than those found in other organs.  
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Sub-localization of gametocytes within the bone marrow 
Localization of gametocytes inside and outside of vasculature.  We aimed to further 
investigate sequestration of immature gametocytes in the bone marrow by expanding our survey 
to a total of 30 patients; specifically, to determine whether sequestering gametocytes across 
patients could be found associated with endothelial cells, analogous to the established adherence 
mechanisms of asexual parasites stages. For this purpose, we performed co-labeling of bone 
marrow sections with markers for the parasite (pLDH or Pfs16) and host vasculature, platelet 
endothelial cell adhesion molecule (PECAM-1), a marker of host endothelial vessels. pLDH-
labeled ring and schizont stages could be observed in the microvasculature, with schizonts 
appearing in contact with endothelial cells (Figure 2.2A) as has been described previously [84]. 
In addition, pLDH-labeled parasites as well as Pfs16-labeled gametocytes were also found in the 
extravascular space of the bone marrow.  Gametocytes of various stages were observed in the 
extravascular space, including small oat-shaped young gametocytes and larger oblong stages 
(Figure 2.2C).  We assessed the intravascular localization of parasites and gametocytes by 
quantifying the number of intravascular pLDH- and Pfs16-labeled parasites in 50 consecutive 
labeled vessels per patient, starting at the upper left corner of each section. And we assessed 
extravascular localization by the number of pLDH- and Pfs16-labeled parasites observed outside 
of labeled vessels in 50 consecutive high power fields, from the upper left corner.  We performed 
both assessments for each of the 26 patients.  Across patients, pLDH-labeled parasites could be 
found within small vessels of the bone marrow, yet very low amounts of Pfs16-labeled 
gametocytes were found inside these vessels, giving in an overall gametocyte fraction of 3% 
intravascularly, across all patients (Figure 2.2B). In fact, across patients, Pfs16-labeled 
gametocytes were found almost exclusively externally, giving a much higher gametocyte 
fraction, 47%, in the extravascular space (Figure 2.2D).  
'-"
Evaluation of phagocytosis of parasites vs gametocytes in the bone marrow. As a large 
number of hemazoin malaria pigment-containing macrophages could be observed in the bone 
marrow, we performed co-localization of gametocytes and total parasites with CD163, a 
macrophage marker, to investigate the fate of parasites within the bone marrow.  We found that 
across patients, large numbers of pLDH-labeled parasites could be found within the cytoplasm of 
CD163-labeled macrophages.  This occurred to a lesser extend with Pfs16(+) gametocytes, 
suggesting that gametocytes in the bone marrow are less susceptible to phagocytosis than asexual 
stages (Figure 2.2E/F).  This also confirms in vitro data suggesting that macrophages recognize 
gametocytes and phagocytose gametocyte-infected erythrocytes at much lower levels than 
asexual-infected ones[85].  
Ultrastructure of parasites in the bone marrow. Ultrastructural analysis of parasites in a 
patient with 45% gametocyte enrichment in the bone marrow revealed presence of a subset of 
erythrocytes containing large parasites that lack knob structures or any other host cell 
modifications (known to be critical in the process of asexual cytoadherence) (Figure 2.3D). 
Some of these cells could be found adjacent to erythrocyte precursor cells (Figure 2.3C), within 
the extravascular space of the marrow. It has recently been demonstrated that gametocytes are 
knobless throughout their development [33], and the morphology of the knobless parasites we 
observe in the bone marrow is consistent with these data. Parasitized erythrocytes exhibiting 
classic knob structures and other host cell modifications such as Maurer’s clefts were found in a 
subset of parasites observed in the bone marrow (Figure 2.3A) and in high numbers in the brain 
(Figure 2.3E-G).  
 
'$"
 
Figure 2.2. Gametocytes are present in the hematopoietic system. (A/C). Gametocyte and 
parasite localization in the bone marrow. pLDH and Pfs16 are detected using AP FastRed 
chromogen (red), endothelial cells labeled with PECAM-1 antibodies and detected with horse 
radish peroxidase (HRP) and DAB chromogen (brown), and nuclei are labeled with Hematoxylin 
stain (blue). Small ring stage (top left) and large adhering trophozoite or schizont stage (top 
right) parasites can be readily identified within the bone marrow sinusoids. Pfs16-labeled 
parasites are predominantly detected outside of the vasculature. Various shapes of developing 
gametocytes can be found (bottom panels). s: sinusoid. h: hematopoietic system. (B/D). 
Quantification of bone marrow sub-localization for Pfs16-positive and pLDH-positive cells. 
Marrows were included if 50 sinusoids could be identified using PECAM-1 labeling. This 
excluded 4 patients due to poor quality of preservation.  For the remaining 26 samples with 
clearly labeled sinusoids, quantities of pLDH and Pfs16-labeled parasites are plotted for 50 
sinusoids (intravascular) in B and 50 high power fields of extravascular space in C. pLDH 
labeled parasites could be observed both in sinusoids and in the extravascular space, while Pfs16 
labelled parasites are almost exclusively detected in the extravascular space. Based on these 
numbers, the gametocyte fractions for intravascular and extravascular localization are shown 
(B/D). (E-F). Parasite and gametocyte localization within macrophages.  Pfs16 and the 
constitutive parasite marker BIP are detected using AP FastRed chromogen (red), and 
macrophages are labeled with antibodies against CD163 and detected using TMB substrate 
(turquoise). While both Pfs16+ and BIP+ cells can be found in macrophages, less than a quarter 
of total parasites within macrophages are gametocytes, as assessed by gametocyte fraction. 
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Figure 2.3. Ultrastructural features of sequestered parasites in the bone marrow. For 
ultrastructural analysis, we performed transmission electron microscopy on the bone marrow and 
brain from a patient previously observed to have a low gametocyte fraction in the brain (6%) and 
a high gametocyte fraction in the bone marrow (45%).  (A-D). Sequestered parasites in the 
bone marrow. In the bone marrow, we observe both (A) characteristic asexual parasites (large 
parasite with knobs and Mauer’s clefts) and (B-C) large knobless parasites characteristic of 
gametocytes. In C, the gametocyte is observed in close association with orthochromatic and 
polychromatic erythrocyte precursor cells. Apart from lack of knobs (D) other features consistent 
with gametocyte morphology include dispersed hemozoin (arrow, B and C) and lack of 
cytoplasmic modifications within the erythrocyte cytoplasm. (E-H). Sequestered parasites in 
the brain. For comparison, sequestered parasites with characteristic asexual morphology are 
present in brain capillaries. Parasites were observed in close contact with each other (G) and with 
endothelial cells (F). Knobs and Mauer’s clefts can be observed on the surface of the infected 
erythrocyte of these cells (H). oc: orthochromatic, pc: polychromatic. mc: Mauer’s clefts.  
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Co-localization of gametocytes within erythroblastic islands.  
Across patients, a large fraction of gametocytes were found to be associated with 
erythroblastic islands, clusters of erythroblasts that adhere to a nursing macrophage during 
development prior to release into the blood circulation [86].  These could be readily identified in 
the bone marrow as clusters of CD71-labeled cells of similar size and morphology, often 
appearing in contact with a hemazoin-containing macrophage (identified morphologically). We 
performed this assessment using Pfs16 and CD71 double-labeled on the eight patients in which 
at least 5 gametocytes were detected in 50 HPF. Gametocyte-infected erythrocytes could be 
observed in contact with erythroblast cells and/or macrophages that composed the island 
structures (Figure 2.4A). We quantified the amount of gametocytes in contact with erythroblast 
islands versus away from islands, and across patients, between 50 to 90% of the gametocytes 
found in the bone marrow were found in contact with these structures (mean of 72% across eight 
patients), (Figure 2.4B).  
 
In vivo development of gametocytes within erythrocyte precursors.   
The transferrin receptor (CD71), as a marker for erythroblasts and reticulocytes, also 
enabled us to quantify the distribution of gametocytes inside erythrocyte precursor cells. We 
observed only a very small fraction of gametocytes within CD71(+) erythrocyte precursor cells 
and only observed this in the two individuals with the highest gametocytemia (Figure 2.4C/D). 
We therefore further examined the patient in which we identified the highest subset of 
gametocytes within CD71(+) cells and performed a size comparison between the gametocytes 
within CD71(+) cells and in CD71(-) cells.  For this analysis, we imaged fifteen gametocytes 
inside CD71(+) and fifteen gametocytes inside CD71(-) cells.  Using the area measurements 
')"
from our in vitro gametocyte stage (Figure 2.1E and Appendix Figure A3), we categorized 
gametocytes as Stage I or Stage II/III gametocytes (none of the gametocytes in this patient were 
measured in the range of Stage IV or V gametocytes). Parasites greater than 7.9 square microns 
in area (lower end of the range quantified for in vitro Stage II gametocytes) were classified as 
Stage II/III, and parasites under this size were categorized at Stage Is.  Over 60% of the Stage I 
gametocytes were found within CD71(+) cells, while under 30% of the Stage II/III gametocytes 
were found within CD71(+) cells.  This suggests that in vivo there is some degree of gametocyte 
development occurring in erythrocyte precursors, and appears to be more specific to young 
gametocytes than older gametocytes (Figure 2.4D).   
 
In vitro development of gametocytes within erythrocyte precursors.  
 Given the enrichment of immature gametocytes in the extravascular space of the bone 
marrow and previous evidence that gametocyte formation is elevated in reticulocyte-enriched 
blood [62,87,88], we wanted to investigate the possibility of gametocyte formation within the 
hematopoietic system in a controlled in vitro setting. In vitro generated human red blood cell 
precursors derived from hematopoietic stem cells [89,90] were incubated with P. falciparum 
schizont stages and development of sexual and asexual progeny assessed. We observed 
continuous development of both asexual and sexual parasites in red blood cell precursors starting 
with the nucleated orthochromatic erythroblast, demonstrating that the hematopoietic system of 
the human bone marrow can support the entire erythrocytic parasite cycle (Figure 2.4E). At Day 
0 (when parasites were added to host cells), host cell population was 41% nucleated and 59% 
enucleated.  By Day 2, we note that asexual development occurs normally, progressing to 
'*"
schizont stage (Figure 2.4E).  Using Pfs16 to label gametocytes, on Day 2, young gametocytes 
are also visible within nucleated and enucleated cells.  On Day 5, intermediate stage II to III 
gametocytes could be observed in these cells, suggesting that gametocyte development occurs 
normally within these cells.  On Day 5, both gametocyte size and host cell age has increased, as 
indicative of higher rates of enucleation (Figure 2.4F).  This suggests that the gametocyte and its 
erythrocyte precursor host cell can develop in parallel, and agrees with the in vivo data we see 
suggesting that early gametocytes are enriched in younger erythrocyte precursors (Figure 2.4D).   
 
 
'+"
Figure 2.4. Gametocyte development within the hematopoietic system. A-D. Gametocytes 
associate with erythrocyte precursor cells in the bone marrow. (A-D) Pfs16 is detected using 
AP FastRed chromogen, and erythrocyte precursor cells are labeled with anti-CD71 (transferrin 
receptor) antibodies and detected with TMB substrate (turquoise). Bone marrows were analyzed 
for 8 patients in which at least 5 gametocytes were detected in 50 high power fields, and the 
number of Pfs16(+) cells is plotted for 50 high power fields (A/B). A large fraction of 
gametocytes observed in these patients were found to be are associated with erythroblast islands, 
specialized niches where red blood cell precursors are eventually enucleated by a nursing 
macrophage and released to enter the blood circulation as reticulocytes. mp: macrophage (C/D). 
Only 2 of these individuals were found to have gametocytes within CD71+ cells, and they made 
up a small fraction in both cases. Gametocyte size was measured using ImageJ and compared 
with in vitro sized gametocytes. For this analysis, 15 gametocytes from within CD71(+) and 15 
gametocytes from within CD71(-) were imaged from the patient with the highest % of 
gametocytes in CD71(+) cells and plotted by proportion CD71-positivity rate for stage I versus 
stage II gametocytes. E. In vitro parasite development in erythroid precursor cells. 
Methylene blue staining was used to confirm the presence of young erythrocytes (which still 
contain RNA, as seen in blue label) in the starting culture, left panel. Asexual development was 
observed to occur within these cells.  In fluorescence images, erythrocyte (wheat germ 
aggultinin, FITC), and nuclei (DAPI) are labeled revealing the presence of schizonts in both 
nucleated and enucleated cells. F. Gametocyte development in RBC precursors. Gametocytes 
(Pfs16, Rhodamine) in addition to erythrocyte and nuclei markers were used in fluorescence 
microscopy to visualize gametocytes in erythrocyte precursors.   
 
',"
 
 
 
 
 
 
 
Figure 2.4 (Continued). Gametocytes could be observed in both nucleated and enucleated 
erythroid precursor cells.  Quantification of host cell is shown for each stage of gametocyte, 
morphologically identified based on size. 
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Discussion 
 The data presented here provide evidence for the existence of a genuine developmental 
cycle of P. falciparum gametocytes in the hematopoietic system of the bone marrow. We first 
determined that the bone marrow has a higher gametocyte fraction than any of the other organs 
tested, suggesting a specific enrichment process occurring at that site.  We next showed that the 
expression of young gametocyte genes peaks in the bone marrow, while expression of mature 
gametocyte genes peak in a variety of organs including the bone marrow but also the spleen and 
heart, which could be a result of the presence of circulating blood through these organs. We also 
confirmed through image measurements that vast majority of gametocytes in the bone marrow 
are stage I-III, while the spleen contains a subset of older stage IV-V gametocytes, further 
supporting the notion that young gametocytes are specifically enriched in the bone marrow.  
 We demonstrate that developing gametocytes are present almost exclusively in the 
extravascular space of the bone marrow.  While asexual ring and sequestering 
trophozoite/schizont stages are found inside the small vessels of the bone marrow (and in contact 
with labeled endothelial cells), we find that gametocytes make up less than 5% of intravascular 
parasites. The enrichment of immature gametocytes in the bone marrow appears to come almost 
exclusively from the extravascular space, in which we find that nearly 50% of all parasites are 
gametocytes labeled with Pfs16.  Of these extravascular parasites that are split approximately 
down the middle between asexual and sexual parasites, just 22% of the parasites found inside 
macrophages were gametocytes, as compared with an estimated 78% being asexual.  Given this 
skew, the fraction of parasites successfully sequestered (i.e. escaping immune system) in the 
extravascular space of the bone marrow is above 50%. This further suggests that the bone 
(%"
marrow is likely a specialized site for sexual development, and not necessarily a favorable niche 
for parasite development generally. 
 At an ultrastructural level, we observed a subset of bone marrow-residing parasites that 
lack knobs and other host cell modifications known to be critically important to the process of 
cytoadherence in asexual stages. Considering that they are not efficiently recognized by 
macrophages (Figure 2.3E/F and [85]) nor induce host immune responses [93] it is possible that 
sequestered gametocytes lack immunogenic antigens on the host cell surface altogether. This 
supports our hypothesis that the underlying mechanism of gametocyte sequestration is 
fundamentally different from the established vascular endothelium cytoadherence model taken 
from asexual parasite biology. 
 Using CD71 to label erythroblasts in the hematopoietic environment, we were able to 
localize gametocytes within erythroblastic island structures.  Gametocytes had a very high rate of 
co-localization with these structures across patients, with gametocyte-infected cells appearing in 
close contact with CD71(+) erythroblasts and/or the nursing macrophage to which they were 
attached.  A mean of 72% of gametocytes from eight patients were observed at these structures. 
 Further, we identified a small subset of bone marrow-residing gametocytes that co-
localized inside CD71(+) cells. As CD71 antibody decreases significantly during erythroblast 
development, trailing off in the late normoblast and reticulocyte [94] and Pfs16 does not label 
gametocytes during the first approximately 24 hours of development (Appendix Figure A3), it is 
possible that the proportion of detected gametocytes within erythrocyte precursors, particularly 
reticulocytes, is underestimated in our analysis. 
(&"
 While this phenomenon was rarely observed in our in vivo bone marrow samples, we did 
observe that in the one patient for which we had enough cells to quantify, stage I gametocytes 
were found at a higher rate within CD71(+) cells, as compared with CD71(-) cells. Using an in 
vitro erythrocyte development system, we observed that gametocytes can grow and develop 
within erythrocyte precursors (orthochromatic cells and reticulocytes).  This suggests that 
gametocyte development could occur within the hematopoietic network, which is predominantly 
made up of erythrocyte precursor cells.  In vitro, we note that the fraction of stage II/III 
gametocytes within nucleated erythrocytes (a marker of young age) is lower than it was when 
these gametocytes were stage Is. Both this and the in vivo observation support the possibility that 
early gametocyte and its host cell can age in parallel. 
 There is a need for a paradigm shift in our conceptualization of gametocyte sequestration 
as an increasing body of evidence suggests that this process occurs through a process distinct 
from that of asexual parasites.  We therefore propose a series of possible models for the 
enrichment of immature gametocytes in the bone marrow parenchyma. 
('"
 
Figure 2.5. Hypothesized models for sequestration of gametocytes in the bone marrow 
parenchyma. (A). Extravasation of parasites into the extravascular space of the bone 
marrow.  Both asexual and sexual parasites are found within the extravascular space of the bone 
marrow (Figure 2.2). Parasites might enter as merozoite progeny from a schizont sequestered in 
the bone marrow sinus (A1), as asexual stage parasites, as ultrastructural bone marrow studies 
suggest this is possible in vivo [91] (A2), or as young sexual stage parasites that home to the 
bone marrow through receptor-ligand interactions (A3). (B). Invasion and growth of young 
gametocyte within erythrocyte precursor cells.  Following schizont burst inside or just outside 
the marrow, merozoites will attempt to invade the nearby erythrocyte precursor cells. The young 
gametocyte can invade and grow within orthochromatic erythroblasts and reticulocytes (Figure 
2.4).  (C). Development of immature gametocytes (stage I-IV) within the hematopoietic 
environment.  The gametocyte requires 8 to 10 days to develop prior to reaching maturity.  
During this time, the gametocyte could remain in the hematopoietic environment due to the lack 
of immune recognition (Figures 2.2, 2.3), and possibly with the help of a binding interaction with 
erythroblast islands (Figure 2.4) and/or an increase in rigidity that prevents their exit [38,39,92]. 
(D). Maturation and release of gametocyte (stage V) into circulation. The release of the 
mature gametocyte into the bloodstream could result from its de-attachment from the 
erythroblast island (possibly due to reduction in ligand expression as its host cell ages), and/or its 
increased deformability. 
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 It remains to be shown which parasite stage (i.e., merozoite, asexual stages, or 
gametocyte stages) crosses the endothelial barrier to enter the bone marrow parenchyma. One 
possibility is that asexual schizonts, sequestering in the bone marrow sinus (Figure 2.2A and 
[91]) release merozoites, that cross into the extravascular compartment (Figure 2.5 A1). The 
small size of the merozoite stage may facilitate its passage through the discontinuous endothelial 
barrier of bone marrow sinusoids.  Alternatively, the asexual infected erythrocyte could 
potentially extravasate through the endothelium (Figure 2.5 A2). In ultrastructural studies of 
parasites in the bone marrow, cytoplasmic processes of infected erythrocytes can be observed 
emerging through the endothelium and into the extravascular space [91], appearing as though 
these infected erythrocytes can transverse this barrier. 
 In either the A1 or A2 scenario, the progeny merozoites from bone-marrow-residing 
schizonts (either in sinus or in parenchyma) could have potentially access to the erythrocyte 
precursor cells of the bone marrow.  Our observation that young stage I gametocytes can be 
found in erythrocyte precursors both in vivo in the extravascular space of the bone marrow as 
well as in our in vitro model demonstrates that these cells can support invasion and growth of 
gametocyte stages.  Previous studies in P. falciparum and the rodent malaria model have shown 
increased gametocyte levels in reticulocyte-enriched blood [87,88,95]. However, it is unclear 
whether gametocytogenesis is triggered in the presence of these reticulocytes, if gametocyte-
committed merozoites preferentially invade reticulocytes, or if gametocytes preferentially 
survive within these reticulocytes possibly due to their high nutrient content (Figure 2.5B).  An 
alternative mechanism to explain this enrichment is that there is a link between schizont 
comittment to gametocytogenesis and the bone marrow environment. Certain environmental 
factors (such as the byproducts of burst erythrocytes and parasite conditioned medium) are 
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known to trigger gametocyte formation and therefore it is possible that the bone marrow 
environment itself trigger comittment to sexual development (Figure 2.5 A2). Or alternatively, 
that committed schizonts formed elsewhere in the body specifically home to the bone marrow 
due to the expression of a particular PfEMP1 ligand that result in cytoadherence in bone marrow 
sinusoids (Figure 2.5 A1). 
 Another possible pathway for gametocyte enrichment in the extravascular space is that 
the young gametocyte itself homes to the bone marrow through a receptor-ligand interaction, and 
then crosses into the parenchyma (Figure 2.5 A3).  This hypothesis is supported by data 
suggesting that gametocytes can bind (albeit weakly) to bone marrow endothelial cells [36], and 
that they are still somewhat deformable in their youngest age (stage I), possibly enabling them to 
extravasate into the bone marrow [38,39,92].  In this model, gametocytes would be formed in the 
circulation, and thus, this model does not offer any link between the observed increased growth 
of gametocytes in reticulocyte-rich blood and the enrichment in the hematopoietic system of the 
bone marrow. This model instead argues that these are two independent processes, and that 
gametocytes would form at a higher rate only during anemic conditions when the circulating 
blood contains a higher proportion of reticulocytes [87,88,95].  
 Regardless of how the young gametocyte gets into the bone marrow parenchyma, it is 
unknown through what mechanism the developing gametocytes are retained within it. Adherence 
of erythroblasts to each other and to the central macrophage to form erythroblastic islands occurs 
through expression of a variety of adhesion molecules [86].  This could provide a possible 
mechanism for the sequestering gametocyte to bind within the extravascular space of the bone 
marrow, as the gametocyte would simply have to hijack a system that is already in place to retain 
young erythroblasts as they develop, and release them as they mature. Developing gametocytes 
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could adhere to these islands through their own parasite-derived ligands or possibly, if the 
gametocyte invaded a young erythrocyte (Figure 2.5B), the gametocyte-infected erythrocyte may 
still express receptors (such as erythrocyte macrophage protein, EMP [86]) involved in binding 
to erythroblastic islands, allowing it to stay bound inside the extravascular space attached to 
these structures during the host cell’s development (Figure 2.5C).  If the gametocyte lacks 
parasite-derived ligands on its cell surface (as suggested by Figure 2.2E/F and 2.3B-D), this 
would enable it to survive in the hematopoietic environment undetected by the immune system 
for the 8-10 days of development required to reach maturity.  We cannot exclude the possibility 
that gametocytes express a ligand that is involved in adherence to such structures, yet the 
existing data suggest that immune system does not recognize this ligand.  Alternatively, or 
additionally as a redundant mechanism, the increased rigidity over the course of gametocyte 
development [38,39,92] could lead to the retention of gametocytes within the marrow during 
development.  Gametocytes have been shown to regain deformability upon reaching maturity 
[38], as well as have reduced binding rates in vitro to human bone marrow endothelial cells 
(HBMEC) in Stage V as compared to immature stages [36]. These two properties of the Stage V 
gametocyte could enable them to exit the bone marrow only once they have successfully matured 
to a deformable stage V (Figure 2.5D). 
 As has been demonstrated for other key processes in the parasite life cycle we 
hypothesize that the gametocyte may be co-opting already existing pathways of its host to 
sequester in the bone marrow parenchyma during its development. Our findings have wide 
implications for our understanding of parasite biology, and for the development and application 
of novel intervention strategies to block transmission of this persistent human disease. 
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Abstract 
In the current era of malaria eradication, tools designed to detect the transmissible stage of 
malaria (the sexual gametocyte stage) are critical. Here, we present a method for estimating 
relative amounts of Plasmodium falciparum parasite stages from gene expression measurements. 
These are modeled using constrained linear regression to characterize stage-specific expression 
profiles within mixed-stage populations. We validated inferences both from microarrays and 
from quantitative RT-PCR (qRT-PCR) measurements, based on the expression of a small set of 
key transcriptional markers. This sufficient marker set was identified by backward selection from 
the whole genome as available from expression arrays targeting one sentinel marker per stage. 
When applied in vivo to peripheral blood samples from malaria patients, the system identified 
both immature and mature gametocyte carriers. We present this approach as a resource for 
staging lab and field samples alike and anticipate its applicability in epidemiological studies of 
gametocyte carriage.
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Introduction  
Gametocytes execute substantially different transcriptional programs from asexual 
parasite stages, as has been well studied in vitro [82]. Similar to the sequential dynamics of the 
asexual Plasmodium life cycle [96,97], gametocytes develop in a staged progression from young 
through intermediate to mature cells in preparation for meiosis and further development in the 
mosquito vector. Each of these stages presents a distinct expression pattern and different biology: 
it is hypothesized that young gametocytes are in blood circulation before the intermediate phase 
sequesters for 8-10 days; mature gametocytes are present in circulation for successful 
transmission to the mosquito vector. The switch between asexual replication and sexual 
gametocyte development does not occur ubiquitously in vivo or in vitro, as even the most 
synchronized gametocyte induction protocols result in partially asynchronous and mixed 
gametocyte stages [82]. This problem is compounded in vivo, as blood sampled during infection 
is likely to contain both gametocyte and asexual parasite populations, leading to a highly 
convolved transcriptional mixture. 
In addition to the need to dissect these signatures for analysis of microarray data, it is also 
of interest to develop a field-applicable approach for detecting and quantifying both young 
(earliest indication of conversion to sexual development) and mature (indication of 
infectiousness to mosquito vector) gametocyte stages. Transcriptional approaches such as RT-
PCR, QT-NASBA and RT-LAMP have been developed [48,49,50] using established markers of 
gametocyte development. Population surveys using the mature gametocyte marker Pfs25 QT-
NASBA in particular suggest that between 15-70% of cross-sectional study cohorts [48,52,53] 
and 39-89% of uncomplicated malaria cohorts are Pfs25-positive [51,54,55,56,57,58]. Surveys 
using the putative young gametocyte marker Pfs16 in circulating blood were inconclusive, as 
)'"
they instead revealed a quantitative relationship between Pfs16 transcript and asexual 
parasitemia [49,50]. While these approaches enable sensitive detection of these transcripts, it is 
unclear how the detection of these transcripts - particularly Pfs16 - relates to actual gametocyte 
carriage and thus transmission. 
There are only a few known markers that are specific for young gametocytes [98,99], and 
these have not yet been successfully employed in field studies to quantify this life cycle stage. 
Since the peripheral blood of malaria-infected individuals contains an abundance of asexual 
stages, care must be taken both to identify markers that are highly expressed in young, 
intermediate or mature gametocytes and to computationally separate the expression of marker 
genes from other life cycle stages. Furthermore, the development of a quantitative assay for 
young and mature gametocyte stages using qRT-PCR has thus far been impeded primarily 
because this approach cannot easily distinguish transcript from contaminating genomic DNA in 
the sample when sequences are identical. Unfortunately, the majority of P. falciparum genes lack 
introns and thus have identical sequences for both RNA and DNA. Likewise, most gametocyte 
detection markers lack introns, and little effort has been made to expand this marker repertoire in 
order to design qRT-PCR assays for gametocytes. It is therefore worth identifying novel intron-
containing markers for which exon-exon junction-spanning primers can be designed so that this 
approach can be used for in vivo gametocyte quantification.  
Our goal was thus to develop a new transcript-based gametocyte model that addressed 
these challenges. Using a deconvolution approach, we identified intron-containing markers from 
across the full range of asexual and sexual development. In order to identify expression patterns 
specific to different gametocyte stages, particularly the young stages, existing in vitro 
gametocyte time point samples were re-analyzed to account for their mixed stage composition. 
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We further developed a qRT-PCR assay based on these results and, applying the model in 
reverse, established an algorithm to estimate the amounts of immature and mature sexual and 
asexual stages in a patient sample based on the expression of a small set of stage-specific 
markers—inspired by related approaches that have been used successfully in dealing with mixed 
cancerous/non-cancerous tissue samples [100,101] and with mixed stages of budding yeast 
[102]. 
We describe here a system for estimating the stage composition of mixed-stage samples 
of P. falciparum in laboratory and field samples. This deconvolution approach to gene 
expression analysis allowed us to determine the stage-specific expression of the P. falciparum 
transcriptome, to identify a small set of stage-specific markers from a time course of mixed 
stages, and to subsequently predict the proportions of each stage in independent samples of 
unknown composition. At each stage, we evaluated model error patterns using cross-validation 
among labeled training samples from across 5 in vitro developmental time courses. We finally 
applied the system to: i) microarray- and qRT-PCR-based data from infected blood samples from 
Malawian and Senegalese cohorts, and ii) microarray expression data from drug perturbations 
performed in vitro. In the field study results, we successfully predicted a higher fraction of 
gametocytes in those samples shown to contain gametocytes by thick smear, and show drug 
perturbation data as a proof of concept of a useful in vitro application of this tool. As a 
transmission-focused tool, this system can be applied in epidemiological settings, and as such 
will ideally support efforts directed toward reducing malaria prevalence worldwide.  
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Materials and Methods  
 
Patients and Sample Collection  
Malawi Cohort. Patients who enrolled in an ongoing severe malaria study [73] at the Queen 
Elizabeth Central Hospital during the 2009 and 2011 transmission season were included in this 
study. These patients were between the ages of 1 month to 14 years of age and came from 
Blantyre, Malawi and surrounding areas, where transmission is high and seasonal. All patients 
enrolled in the study met the clinical criteria for severe malaria, and severity was classified by 
Blantyre Coma Score [103]. The majority of patients were treated with an antimalarial drug 
(majority received quinine) within the 24 hours prior to being admitted in the ward.  Parent or 
guardians of all children enrolled in the study were consented in writing in their own language by 
local native-speaking healthcare staff (nurse or doctor).  The institutional review boards of the 
Harvard School of Public Health, Brigham and Women's Hospital, and University of Malawi 
College of Medicine approved all or parts of this study. The samples from the 2009 cohort have 
been described in detail in a recent publication [104]. For the 2011 cohort, a venous blood 
sample was drawn at admission and a 500µl sample of whole blood was added directly to Tri-
Reagent BD (Molecular Research Center), mixed vigorously and stored at -80 C until 
processing. Simultaneously, thick and thin smears were collected and stored for later processing. 
Patients were classified as gametocyte-positive if they had 1 or more gametocytes in 100 thick 
smear high power fields (HPF). For standard gametocyte quantification by thick smear, we 
quantified gametocytes per 500 white blood cells (WBC).  
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Senegal Cohort. Patients who enrolled in a study of uncomplicated malaria in Thies, a low 
malaria endemicity region 70km from Dakar, Senegal in October 2008 during transmission 
season were included in this study. Patients who presented to Section de Lutte Antiparasitaire de 
Thies, with signs and symptoms of malaria were offered enrollment if they had microscopic 
confirmation of malaria infection and had mild symptoms. Institutional Review Board approvals 
were obtained from the Ethics Committee of the Ministry of Health in Senegal and the Human 
Subject Committee of the Harvard School of Public Health. Consent was obtained from the 
patient or a child’s guardian. At the time of admission, a blood sample was taken from which 4.5 
mL was transferred into Tri-Reagent BD, shaken vigorously for 15 seconds, and frozen at -80°C 
for transcriptional analyses. General demographic data, history of illness and hematocrit were 
recorded. Samples were transported to HSPH in a liquid nitrogen charged dry shipper, thawed in 
a room temperature bath and RNA isolated according to manufacturers instructions (Molecular 
Research Center). Simultaneously, thin smears were collected and stored for later processing.   
 
P. falciparum asexual and sexual in vitro culture  
A transgenic line, 164/GFP, of a gametocyte-producing clone of the 3D7 strain of P. falciparum 
was used to produce the mixed stage samples for model training and validation.  This transgenic 
line, which aided in the quantification of gametocyte stages, produces stage-specific GFP 
expression under the PF10_0164 gene promoter, as described previously [105] .  A previously 
characterized non gametocyte-producing clone, F12, of the 3D7 strain was used to confirm 
stage-specificity of gametocyte markers [106].  Culture conditions were as described previously 
[107], maintaining the parasite line in O+ blood at 4% hematocrit in RPMI-1640 media 
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supplemented with 10% human serum.  Cultures were kept at 37°C in a chamber containing 
mixed gas (5% CO2, 5% O2, 90% N2).  Prior to induction, asexual parasite cultures were 
synchronized for two cycles with 5% D-sorbitol [108], and subsequently induction of 
gametocytogenesis was performed according to the Fivelman protocol [74]. Briefly, asexual 
parasites were grown to a high parasitemia in the presence of partially spent (“conditioned”) 
medium, and then sub-cultured at the schizont stage into new dishes containing fresh media and 
erythrocytes.  One of two methods was used to reduce the amount of asexual stages in the 
cultures: Treatment with D-sorbitol was performed two days later to lyse asexual 
trophozoite/schizont stages and selectively enrich for unaffected early gametocytes, or N-acetyl 
glucosamine was added to the medium one day later and every subsequent day to selectively kill 
asexual stages.  
 
Standard and Fluorescence Microscopy 
In order to accurately quantify the stage distribution of parasites in our in vitro samples, we used 
a combination of standard and fluorescence microscopy. Parasite stage distribution was 
monitored throughout the parasite synchronization and induction protocol using Wright’s 
Giemsa stain applied to thin blood smears. Quantification of asexual rings and trophozoite 
stages, as well as developing and mature sexual stages was done directly by light microscopy.  In 
order to quantify early stages of sexual development that are morphologically similar to asexual 
stages, we used a combination of live imaging and immunofluorescence microscopy. Live 
imaging was performed using the transgenic 164/GFP line. Parasites were analyzed using the 
FITC channel on an inverted epifluorescence microscope (Zeiss) and quantification was done of 
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the proportion of GFP positive parasites (gametocytes) out of the total number of Hoechst 
positive parasites. Immunofluoresence assays were performed with cell monolayers on glass 
slides, prepared as described previously [77]. For labeling with the constitutive gametocyte 
marker Pfs16, slides were fixed in ice-cold methanol, blocked with 5% nonfat milk 
(reconstituted from dry powder), incubated with polyclonal mouse antibody against Pfs16 
(1:2500) [78], washed and incubated with a secondary antibody conjugated to Alexa 488 
(Invitrogen). Parasite nuclei were labeled with DAPI and quantification was done on the 
proportion of FITC positive parasites out of the total number of DAPI positive parasites. For 
time points in which we had data from both live and immunofluorescence experiments [78], the 
quantification of early gametocytes from both methods was averaged to give the final amount. 
  
Primer & Probe Design 
We developed a quantitative reverse-transcriptase PCR (qRT-PCR) assay for the quantification 
of five key gene transcripts. The assay includes primers and probes designed against the five 
markers: PFE0065w for the early asexual stage, PF10_0020 for the late asexual stage, 
PF14_0748 for the young gametocyte, PF14_0367 for the developing gametocyte and 
PF11_0209 for a constitutive marker. These are described in more detail in the Results section. 
Primers and probes were designed by hand using the PrimerExpress software (Applied 
Biosystems) and following recommended guidelines for qRT-PCR primer and probe design. 
Primers were specifically designed to cross exon-exon junctions, so as to reduce genomic DNA 
amplification. In addition both primers and probes were checked for homology against 
Plasmodium or human homologous sequences using PlasmoDB and NCBI Blast in order to 
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eliminate the chances of non-specific amplification (see also Appendix Table B4 for primer and 
probe validation).  
 
RNA Extraction, DNAse Digest and Reverse Transcription 
RNA from mixed stage cultures was preserved and extracted and processed as previously 
described [79]. Briefly, samples were stored in TriReagent (Molecular Research Center) until 
use. For sample processing, RNA was extracted by the phenol-chloroform method followed by 
DNAse digest (Ambion), and a second phenol-chloroform extraction for protein removal and 
sample concentration. For first strand synthesis we used the SuperScript III First Strand 
Synthesis kit (Invitrogen).   
 
qRT-PCR Assay Optimization  
Amplification of the correct target sequence was confirmed by gel electophoresis and melt curve 
analysis using SYBR Green (BioRad). The ability of primer pairs to discriminately amplify the 
cDNA product was determined by performing qRT-PCR on mixed stage P. falciparum cDNA 
and genomic DNA (same extraction, minus DNAse digest and reverse transcription for genomic 
DNA). The possibility of non-specific amplification with host template was ruled out by 
performing qRT-PCR on cDNA and genomic DNA from a human whole blood sample from 
which GAPDH was successfully amplified (data not shown). Primer pair efficiencies were 
determined by calculating the slope of the crossing threshold (CT) values on 10-fold serial 
dilutions of mixed stage cDNA (Appendix Table B4).  
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Sensitivity Assessment  
Sensitivity of this assay was determined using 10-fold serial dilutions of mixed stage cDNA. 
Sensitivity was estimated by calculating the amount of parasites of each stage that were present 
in the sample at the limit of detection by qRT-PCR. 
 
Microarray expression analysis of Senegalese patient isolates 
Peripheral blood RNA (Senegal patients only) was assessed by bioanalyzer and RNA Integrity 
Number, and high quality RNA samples were labeled and hybridized to an oligonucleotide array 
(Affymetrix) custom-designed for the P. falciparum 3D7 genome, PlasmoFB, as published 
previously [97]. The raw CEL files were condensed into GCT expression files using RMA and 
the default parameter settings in ExpressionFileCreator in GenePattern [109]. 
 
Development and validation of the constrained linear regression model  
Development. A constrained linear regression model was constructed to estimate the 
contribution of each stage to the overall transcript abundance from training data. Stages include: 
asexual ring (R), asexual trophozoite/schizont (T), immature gametocyte (IG), mature 
gametocyte (MG) for the 5 marker model.  For the 6 marker model, IG is split into young 
gameotcyte (YG) and developing gametocyte (DG).  For any transcriptional signature that 
cannot be assigned to one of these groups, it is assigned as unknown (U). 
The total transcript abundance yg for each gene g was modeled as a mixture of its abundance in 
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each specific stage U, R, T, IG or YG+DG and MG. The mixture fraction xs represents the 
proportion of parasites in each stage s and is thus constrained between zero and one. 
Microarray model training to establish genome-wide stage-specific expression. This model 
was first fit to estimate the contribution of each stage to each transcript's abundance, parameters 
!g,s. Labeled training data were obtained from a published in vitro time course [82,97] in which 
the stage-specific parasite fractions xs were known from fluorescence microscopy. The model 
was fit to these training data using lm, the linear model method without an intercept, in R, 
resulting in a table of 5,159 genes across the five erythrocyte stage-specific parameters 
(Appendix Table B1). 
 
Gene Set Enrichment Analysis 
GSEA was performed using the pre-ranked !g,s parameters determined in this manner in 
combination with a newly derived set of P. falciparum-specific gene sets. For this purpose P. 
falciparum Gene Ontology [110] leaf annotations were obtained from PlasmoDB and propagated 
into the ontology using the Sleipnir functional genomics library (34). Gene sets containing <2 
genes were removed, and overlapping gene sets were merged (combining the top 10% of gene 
set pairs ranked by the fraction of shared genes relative to the total size of the smaller set). These 
gene sets were finally combined with the P. falciparum pathways from KEGG [111]. Enrichment 
of the resulting pathway sets (Appendix Table B3) was then assessed in the five pre-ranked 
parameter lists using GSEA over 1000 bootstraps.  
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Model application to predict stage distribution 
Given the learned model parameters !g,s from stage-labeled data with known xs, the model was 
inverted to infer the unknown stage distributions xs in new samples. A quadratic programming 
approach was used to solve the system of linear equations with the constraint that the proportions 
of all stages must sum to 1:  
y = !"x  
subject to 
s!{U ,R,T ,IG ,MG}
" xs = 1  
and x ! 0  
 
We implemented this process in the R function quadprog and solved for the stage distributions 
using the sets of six (for microarrays) or five (for PCR data) markers ultimately selected as 
follows. 
 
Co-Normalization of Reference and Inference Data Sets. 
Microarray data sets. For model inference in microarray data, missing values remaining in 
input microarrays were imputed per dataset using the row mean across all samples. For each set 
of two or more training and inference datasets obtained in different batches, values used in the 
modeling process were co-normalized using quantile normalization. Datasets were first merged, 
retaining only gene names common among both datasets and the resulting merged data was 
jointly quantile normalized. 
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qRT-PCR data sets. Similarly for qRT-PCR expression values, raw values were de-logged 
using the formula to bring the data into a range of log-scaled abundance counts comparable to 
microarray samples. Missing values were imputed to the lowest detectable limit on our qRT-PCR 
assay, which corresponds to a CT value of 50 or 3.23 in de-logged expression space. Again 
considering sets of reference and inference data together, data were median normalized, such that 
all samples had the same median value (i.e. adjusting expression values by subtracting the 
column median and adding the global median). 
 
Stepwise Backward Marker Selection 
To identify reduced marker sets appropriate for inference, we used the model's inference process 
to perform in silico marker selection based on greatest accuracy of stage inference in our labeled 
microarray training data. Iteratively, model inference was performed on the total labeled 
microarray time courses using the complete transcriptome. Each individual gene was removed, 
the model re-applied, and the marker inducing the smallest increase in inference error removed. 
These steps were repeated to a minimum of five markers, and the entire process repeated 15,000 
times. The resulting whole transcriptome rankings were averaged to assign a rank-average 
selection preference to retention of each Plasmodium gene as one criterion for our reduced 
marker set. 
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Bootstrap Cross Validation 
The model's accuracy in each labeled microarray and qPCR training set was evaluated by 10-fold 
bootstrap cross validation. For each fold, one third of conditions were selected for holdout with 
replacement to form a test set. The model was fit as above to the remaining training data and its 
accuracy in predicting new expression samples was calculated using a per stage root mean square 
error in the test set.  
 
Results 
A regression model characterizing genome-wide stage-specific expression in P. falciparum  
Calculation of gene-specific expression contributions to each life cycle stage. To identify 
expression patterns of individual stage categories while accounting for mixed stage composition, 
we began by using a labeled set of microarray data with asexual and gametocyte proportions 
assessed manually by microscopy [82,97]. For our purposes, we divided the P. falciparum intra-
erythrocytic development into categories that reflect physiologically relevant distinctions during 
the course of natural infection in the human host. Specifically, we separated those phases found 
sequestered in tissues from those found in circulation, resulting in a total of five categories. 
These included two asexual categories, i) the circulating ring stage (termed “R”) and ii) the 
sequestering trophozoite and schizont stage (termed “T”). The three gametocyte categories were 
i) the young gametocyte ring and Stage I (termed “YG”), which are hypothesized to circulate, ii) 
the sequestering developing gametocyte stages II, III, IV, (termed “DG”) and iii) the circulating 
mature stage V gametocyte (termed “MG”). For most analyses, we grouped YG and DG together 
as one category encompassing all immature gametocytes (termed “IG”).  We subsequently 
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constructed a constrained regression model to identify the degree to which each P. falciparum 
gene's expression varied with respect to life cycle stage (Figure 3.1).  
 The model parameters encode the relative expression of each gene that can be attributed 
to each life cycle stage, five of which are described above and a sixth category representing 
transcriptional activity not well-captured by any of these (Figure 3.1A). The model was initially 
fit using microarray expression data from three time courses spanning the P. falciparum intra-
erythrocytic life cycle wherein the stage distributions at each of the time points were determined 
by microscopy [82,97] (Figure 3.1 D1). 
 In any one time point or sample, the total transcript abundance yg for each gene g was 
modeled as a mixture of its abundance in each specific stage. The mixture fraction xs represented 
the fraction of parasites in stage s (Figure 3.1B), and the model was constrained to require the 
sum of xs across stages to remain equal to one. The contribution of each stage to g's overall 
transcript abundance was captured as !g,s parameters which provided not only predictive 
accuracy but were also used to identify stage-specific gene sets and pathways (Figure 3.1 D2). 
After identifying each gene g's stage-specific parameters !g,s, but before winnowing them down 
to a minimal set of markers for qRT-PCR, we inspected the resulting genome-wide 
characterization of P. falciparum life cycle transcriptional activity in order to identify stage-
specific pathways and regulatory mechanisms. 
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Figure 3.1. In silico dissection approach involving a linear regression model to identify 
stage-specific gene expression profiles within bulk population gene expression. (A). 
Definition of physiologically relevant stage categories within P. falciparum development for 
which we will identify stage-specific gene signatures.  Stages are as follows: R: asexual ring, 
T: asexual trophozoite and schizont, YG: young gametocyte ring and stage I, DG: developing 
gametocyte stages II, III, and IV, IG: all immature gametocytes (YG + DG), MG: mature 
gametocyte stage V, and U: unexpected profile not captured by our defined stages. (B). Linear 
regression model for the deconvolution of bulk gene expression data from mixed stage 
samples. Terms are as follows: yg: total expression of gene g, !g,s: expression of gene g attributed 
to stage s, Xs: proportion of the sample that is stage s. (C). Marker Selection. Filters used to 
narrow down gene sets to our set of sentinel markers for field-applicable qRT-PCR assay. As we 
chose markers for ring and trophozoite/schizont stages a priori based on published stage-specific 
gene expression data for asexual development [96,97,112], we used this selection method to 
identify markers for the remaining gametocyte stage categories. (D). Overall stage prediction 
schematic.  
*+"
 
 
 
 
!
"
#
! " #$ %$ &$ '
()*+,-./)
0*1)23,4-56-
4,78.,4-
0*),+/38,9
()*+,:91,08780-+,.,-,;13,998/.-<.=>?@A
B.)3/.:0/.)*8.8.+-<.=@CDA
()*+,:91,08780-13/),8.-,;13,998/.-<.=@>A
E,3878,4-56-F*99-91,0-,G84,.0,
H38F,3-4,98+.
I3/99-,;/.-J2.0)8/.9K-*G/84-(LH9
!"#$%&'(-G*M84*)8/.-/7-9)*+,:91,087808)6
!"#$%$(-G*M84*)8/.-/7-78,M4-*11M80*58M8)6
$ N
O
P
@
Q
B.12)-)3*8.8.+-4*)*
$,.,-,;13,998/.-4*)*
<&803/*33*6A
R./S.-9)*+,-0/F1/98)8/.
<&803/90/16A
()*+,-4,78.8)8/.-*.4-0*M02M*)8/.-/7-9)*+,:91,08780-+,.,-,;13,998/.
B4,.)8780*)8/.-*.4-0T*3*0),38U*)8/.-/7-9)*+,:91,08780-F*3V,39
(*+,:91,08780-+,.,-9,)
-84,.)8780*)8/.
&*3V,3-9,M,0)8/.-*.4-
HI!-G*M84*)8/.
()*+,-13,480)8/.9-*.4-03/99:G*M84*)8/.-/.-F803/*33*6-4*)*
B.7,33,4-9)*+8.+-73/F-
)3*8.8.+-4*)*
W33/39-1,3-9)*+,-4238.+
03/99:G*M84*)8/.
()*+,-13,480)8/.9-/.-1*)8,.)-4*)*
&*M*38*-1*)8,.)9 B.7,33,4-9)*+8.+-/.-
1*)8,.)-9*F1M,9
B$
()*+,-%,78.8)8/. !,+3,998/.-F/4,M
 
)*-=--           ---------------- *+,-,-X- ! ! ! !
! 9 Y!K"K#$K%$K&$K'Z-
- -
!
 
)*-=--           ---------------- *+,-,-X- ! ! ! !
! 9 Y!K"K#$K%$K&$K'Z-
- -
!
*,"
Definition of stage-specific gene sets reveals parasite biology. The model parameters !g,s 
provided a measure of the amount of expression of each gene attributable to each stage s. To 
initially identify genes with stage-specific regulation, we selected those genes for each stage 
where !g,s was at least two (for sexual stages) or one (for asexual stages) standard deviations 
further above mean than for any other stage. This process resulted in 637 stage-specific genes 
distributed across five stages: 154 (R), 34 (T), 229 (YG), 34 (DG) and 186 (MG), with the top 
fifteen individual stage-specific markers appearing in Figure 2A (see Appendix Table B1 for 
genome-wide analysis).  
 
Gene set enrichment analysis. Prior to selecting individual stage-specific genes from these data, 
stage-specific pathway activity was assessed genome-wide using Gene Set Enrichment Analysis 
(GSEA). Since the standard gene sets available for GSEA are somewhat sparse for P. 
falciparum, a pathway database was constructed using the gene annotations in PlasmoDB for the 
Gene Ontology [110] (see also Appendix Tables B2 and B3). These gene sets were then used 
with GSEA on our model parameters, employing the genome-wide !g,s parameters z-scored 
across stages as a pre-ranked statistic for enrichment testing. The resulting stage-specific 
pathway enrichments included biological activities that are known to be associated with 
particular stages in the asexual cycle, such as host cell remodeling in ring stages (R) and host cell 
invasion and replication in the later stages of the asexual cycle (T). Our analysis supports earlier 
observations from the initial gametocyte transcriptome study and a more recent early gametocyte 
protreome [82] that mitochondrial and lipid metabolism are significantly up-regulated during 
early sexual development [82], as well as factors involved in cell cycle control. We also 
observed enrichment of endocytic pathways and cytoskeletal remodeling during later stages of 
+-"
sexual development. These processes are likely linked to hemoglobin uptake and exflagellation 
during male gametogenesis, respectively (Figure 3.2B and Appendix Table B2).  
 
Signatures of natural selection. Interaction with the host immune system can result in a higher 
rate of single nucleotide polymorphisms (SNPs) in genes involved in these interactions. Since 
life cycle stages vary in their level of interaction with the host immune system, we were 
interested in whether any of our stage-specific gene sets varied in signatures of natural selection. 
As a measure for balancing selection within a parasite population, we determined the genetic 
diversity of individual genes within the three gametocyte stages and two asexual stages (Figure 
3.2C). For this purpose, we calculated SNP ! values for each gene based on a sequence 
comparison from 25 culture-adapted strains from Senegal [113].  SNP ! quantifies the average 
number of pairwise differences among a set of strains at a set of assayed SNPs. As a 
complementary measure for positive selection between populations, we also calculated Fst [114] 
when comparing the 25 strains from Senegal with a reference line from Honduras, HB3 [115]. 
Our analysis demonstrated that none of the genes from within the set of highly stage-specific 
asexual and sexual markers are under increased selection compared to the genomic average, 
neither within a population nor between two populations. This suggests that the stage-specific 
transcripts identified by this process are enriched, by these criteria, for gene products core to the 
regulatory program or stage transitions themselves, excluding proteins that would interact more 
directly with the host. Such conserved genes are likely to serve as robust markers in lab and field 
samples alike. 
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Figure 3.2. Stage-predictive gene sets are enriched for specific biological processes but 
show no signature of selection by diversity/divergence measures. (A). Top 15 model !g,s 
parameters specific to each stage; values indicate for each gene the degree of its expression 
attributed to each stage. (B). Gene set enrichments of GO and KEGG processes by stage 
(Appendix Table B2). (C). Diversity (within patient) vs. divergence (between isolate) of the 
P. falciparum genome (see methods for data sources), highlighting genes identified as stage-
specific. Several known diverse/divergent (antigenically variant) markers are labeled for 
comparison.  
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Selection and validation of a sentinel marker set for stage prediction  
Marker selection overview. After characterizing the genome-wide sexual stage-specific gene 
expression of P. falciparum, we proceeded to identify a small subset of markers to sufficiently 
recapitulate genome-wide resolution for stage prediction. To combine predictive accuracy with 
biological interpretability, we chose to identify the single markers representing each stage 
category while still minimizing prediction error. This resulted in a set of filtering criteria to 
obtain markers validated to be stage-specific and suitable for use in qRT-PCR (Figure 3.1C and 
3.1 D3).  
 
Selection of asexual-specific and constitutively expressed markers. To identify optimal 
markers for the better studied asexual R and T stages, we began with the stage-specific gene sets 
identified for each stage and first filtered based on presence of intron(s). We also required mass 
spectrometry evidence confirming the protein is expressed during asexual development, as 
determined using the available databases as published through the Plasmodium Genomics 
Resource Database (PlasmoDB). Next, we ranked genes based on frequency of retention during 
model predictive marker selection (see Methods) and used raw expression information such as 
lack of allelic expression variation, high absolute expression levels [97], and stage-specific 
expression evidence by expression timing [96] as additional filters. Based on this process, we 
selected PFE0065w for the early asexual stage (R). It encodes skeletal-binding protein 1 (SBP1), 
a well-characterized component of parasite-induced membrane structures in the host red blood 
cell (RBC) termed Maurer’s clefts [112,116].  Using these same criteria, we selected PF10_0020 
as the late asexual stage (T) marker. The gene encodes a protein that is predicted to be secreted 
+&"
into the host RBC [117] and contains a putative alpha/beta hydrolase domain. It is highly specific 
for late asexual stages not only based on the !g,s parameter, but also based on its independent 
gene expression profile from a comparative transcriptional analysis of three P. falciparum strains 
[96]. For the baseline marker, we chose a constitutively expressed transcript as determined by 
ranking all P. falciparum genes by the lowest standard deviation across life cycle stages [82,97] 
and patient isolates [80] and using a cut-off for high expression (Appendix Table B1). The 
selected marker PF11_0209 encodes a conserved protein of unknown function. 
 
Selection of gametocyte stage-specific markers. To select gametocyte markers, we began with 
the stage-specific gene sets identified for each stage category as above (YG, DG, or MG) and 
filtered first based on the presence of intron(s). Next, we retained only those genes in which mass 
spectrometry data again confirmed expression in the gametocyte development and absence in 
asexual development, providing evidence both for stage-specific activity and lack of evidence for 
non-specific stages. These criteria revealed a shortlist of gametocyte-specific candidates with 
high predictive accuracy, but in the case of the MG stage, no markers showed high and stage-
specific expression levels (as defined by the !g,s parameter) comparable to the currently used 
gametocyte marker Pfs25. We therefore decided to include Pfs25 as a MG marker to model stage 
distribution in microarray data, as the major criterion against using it for qRT-PCR (i.e. absence 
of an intron), does not apply to the analysis of chip-based data. For the remaining gametocyte 
stage categories in which highly expressed markers were successfully identified, we ranked gene 
lists based on frequency of retention during model predictive marker selection and selected 
PF14_0748 and PF14_0367 to represent young (YG) and developing (DG) gametocytes, 
respectively. PF14_0748 has previously been identified as an early gametocyte marker [82,98], 
+'"
and we have recently demonstrated that its promoter can drive gametocyte-specific reporter 
expression [105]. It encodes a protein predicted to be exported into the host RBC with a putative 
PHIST domain [117]. PF14_0367 has not been described previously.  
 
Initial validation of the model on microarray samples. With a set of six sentinel markers 
identified, we proceeded to test their ability to predict stage distributions in silico, first using 
cross-validation over the available labeled microarray data (Figure 3.1 D4). Having fit the 
complete regression model to establish !g,s parameters, we subsequently retained only those six 
markers' values for prediction of a sample’s stage composition. This was done by solving for Xs, 
the percent composition of each stage, while employing a quadratic programming approach to 
constrain the proportions of these stages to sum to 1. Making predictions based on gene 
expression from our selected marker set, we successfully predict the transition from asexual to 
sexual development across the life cycle time course (Figure 3.3A/B). Prediction errors 
generated through cross-validation were minimal, with total per stage, per sample, root mean 
squared error of 0.195 (Figure 3.3C). 
 
 
 
+("
 
Figure 3.3. Marker selection yields a set of sentinel markers with high predictive accuracy. 
(A) Actual and (B) inferred stage distributions across five microarray time courses (two 
asexual and three sexual) with reference stage distributions determined by microscopy. Six 
markers were used to make these predictions, five as identified through filtering criteria (Table 
3.1) and the previously established mature gametocyte marker Pfs25. (C). Bootstrap cross-
validation of error rates expected per stage in model inferences. Violin plots show expected 
density, with internal boxplots detailing the 25th – 75 th percentiles and 1.5x fences.  
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Table 3.1. Genes used in qRT-PCR Assay.  
Name Accession  Stage-Specificity PCR Efficiency Limit of Detection 
Skeleton-binding 
protein 1 (SBP1) PFE0065w ring 90.43% 
10
1
 pg cDNA  
(appx 30 rings) 
Alpha-beta hydrolase, 
putative PF10_0020 
trophozoite/ 
schizont 
87.82% 
10
3
 pg cDNA 
 (appx 1000 
troph/schizonts) 
Plasmodium exported 
protein (PHISTa) PF14_0748 
early - mid  
gametocyte 
92.17% 
10
2
 pg cDNA  
(appx 30 immature 
gametocytes) 
Conserved 
Plasmodium protein PF14_0367 
mid - late  
gametocyte 
89.77% 
10
3
 pg cDNA 
 (appx 20 mature 
gametocytes) 
Conserved 
Plasmodium protein PF11_0209 all stages 92.06% 
10
2
 pg cDNA 
 (appx 500 total 
parasites) 
 
Table 3.1. Details of the qRT-PCR compatible marker set selected by our combined filtering 
process. PCR efficiency was calculated based on the slope of the line after running a series of 10-
fold dilutions of mixed-stage cDNA (Appendix Figure B3). Limit of detection was calculated 
based on the number of parasite stages estimated to be present in the last dilution where the 
marker was detected.  Detection limit ranged from 101 – 103 pg cDNA, corresponding to 
approximately 20 - 200 cells, depending on the stage. 
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qRT-PCR gametocyte stage quantification using the sentinel markers  
 We next sought to test an extension of the microarray-based model to transcriptional 
measurements obtained by PCR, which might eventually be more appropriate for a field assay. 
As no MG marker that achieved our filtering criteria (see Figure 3.1C) for qRT-PCR also 
matched both the high expression levels and stage-specificity of the existing Pfs25 marker for 
gametocyte detection, we assessed the utility of the YG and DG markers in combination for the 
prediction of gametocyte quantities when applying the model to qRT-PCR data. Specifically, 
PF14_0748 and PF14_0367 were likely to represent immature (IG) and mature (MG) 
gametocytes in combination, as PF14_0367 had a !g,s parameter similar to that of Pfs25 in 
mature gametocyte stages. We therefore cross-validated this 5-marker PCR set (Table 3.1) 
comparably to the 6-marker microarray set, using the in vitro microarray time courses as 
described above. The simplified model remained able to predict stage distribution accurately, 
with a root mean squared error comparable to that of the 6-marker model (Appendix Figure B1). 
 In order to create a qRT-PCR assay for our sentinel transcripts, we designed exon-exon 
junction spanning primers (distinguishing transcripts from genomic DNA) and sequence-specific 
probes (distinguishing transcripts from non-specific background amplification). Following 
confirmation that our primer/probe sets selectively amplified cDNA and not DNA or non-
specific products, we validated the stage-specific expression using in vitro-derived asexual and 
sexual stage RNA (See Appendix Figure A3 for optimization and validation of qRT-PCR 
parameters). For this, we used the gametocyte-producing reference line 3D7 and a gametocyte-
deficient clone thereof (termed F12 [106]) to confirm the stage-specificity of each of our sentinel 
markers. Normalized expression data from time courses of 3D7 and F12 confirmed stage-
specificity of our sentinel marker set (Appendix Figure B3). The asexual markers alternate with 
++"
respect to time points in which there were predominately rings or trophozoites and schizonts in 
the culture, with similar results for both the F12 and 3D7 lines. The sexual markers demonstrate 
stage-specificity within the 3D7 time course and no appreciable expression in the F12 line once 
normalized (Appendix Figure B3). Specifically, PF14_0748 expression is detected in the early 
and mid gametocyte time points, while PF14_0367 expression is detected in both mid and late 
time points. 
 
In vitro stage prediction using qRT-PCR. Having validated the stage-specificity of each 
marker in vitro and tested their predictive-ability as a set in silico, we next compiled a larger set 
of in vitro samples in order to tune a set of model parameters for stage prediction specifically 
using qRT-PCR-based expression measurements. This required a set of P. falciparum expression 
samples assayed by qRT-PCR and labeled with known distributions of parasite life cycle stages. 
For this purpose we used the data from our in vitro validation on the 3D7 and F12 lines, in 
combination with additional in vitro samples generated from across a 48-hour period of asexual 
development, and a two-week period of gametocyte conversion. For the additional data points, 
we used a transgenic line in 3D7 background, termed 164/GFP, that expresses fluorescent 
protein under the gametocyte-specific PF10_0164 promoter [105]. This parasite line enabled us 
to determine stage composition with high accuracy by both Giemsa stain and fluorescence 
microscopy throughout gametocyte development and starting at the earliest stages (Appendix 
Figure B4). The model was trained on these qRT-PCR datasets as described earlier for 
microarray data, again determining the contribution !g,s of each stage to our five markers' 
expression and performing cross-validation to evaluate the final prediction error rates per stage. 
Again, we see that the model accurately predicts the absence of sexual stages in F12 and low 
+,"
parasitemia cultures of 3D7, while predicting young gametocytes in the high/stressed 3D7 
cultures, and developing and mature gametocytes in the later mixed gametocyte induction 
cultures (Figure 3.4C).  
 
Application of the qRT-PCR and model predictions to a cohort of severe malaria cases. To 
test the sensitivity of our system in an epidemiological context, peripheral blood samples from a 
cohort of severe malaria patients in Blantyre, Malawi were collected over the course of the 
malaria transmission season in 2011 (see Table 3.2 for patient cohort characteristics). Ring 
parasitemia was quantified using standard methods (thin smear microscopy and grid) and 
gametocyte quantification (thick smear microscopy screen of 100 high power fields for 
positivity, then quantification against 500 white blood cells, see Figure 3.4D). Of the 86 samples 
examined, 8 were gametocyte-positive by thick smear. These 8 samples were  matched with 8 
gametocyte-negative samples with equivalent parasitemia and qRT-PCR was performed. Seven 
of the 8 (88%) microscopy-positive gametocyte carriers were qRT-PCR positive for one or both 
gametocyte markers, while only three of the 8 (38%) matched microscopy-negative individuals 
were positive for either gametocyte marker, with highest levels of expression were observed in 
the gametocyte carriers (Figure 3.4E). The model predicted that most patients have a ring-
dominated profile, as we expect to see in peripheral blood (Figure 3.4F).  A number of 
individuals were predicted to have trophozoites and schizonts, which has been shown to be 
associated with severe malaria [118] and was observed in a subset of the smears from this cohort. 
The model predicts gametocyte fractions in four patients, all of which were gametocyte-positive 
by thick smear. 
,-"
 
 
Figure 3.4. qRT-PCR Assay Optimization. (A). Absolute number of parasites stages that 
went into each qRT-PCR reaction well for a range of in vitro time points with varying 
contributions of asexual and sexual stages, from both gametocyte-producing and non-
producing lines of 3D7. (B). Relative qRT-PCR-based gene expression of stage-specific 
markers for T, IG and MG are shown for time points corresponding vertically to those in part 
A. (C). Inferred proportion of each stage in the total parasite load (model predictions) are 
shown corresponding vertically to the time points in A and B, plotted as a percentage of total 
parasites in that sample. (D). Absolute number of parasites stages per uL of blood, as 
determined by microscopy for in vivo peripheral blood samples from severe malaria 
patients in Blantyre, Malawi.  (E). Relative qRT-PCR-based gene expression of stage-
specific markers for T, IG and MG (normalized to SBP1; value of SBP1 not plotted because 
this asexual ring marker was detected in all samples) are shown for time points corresponding 
vertically to those in part D. (F). Inferred proportion of each stage (model predictions) are 
shown corresponding vertically to the time points in D and E. Stars indicate subjects in which 
gametocytes were observed by thick smear examination (1 or more gametocytes in 100 high 
power fields). 
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Table 3.2. Admission characteristics of severe malaria patients tested by qRT-PCR, 
Blantyre, Malawi, 2011.  
Demographics 
Mean age (months) 52.9 
Age range (months) 5-156 
Gender 47.3% female 
Parasitemia 
Geometric mean parasite density/#l [95% CI] 48349 [29051 – 80466] 
Median parasite density/#l 74800 
Parasite density range/#l 69 - 945500 
Gametocytemia 
Gametocyte prevalence (Screen of 100 HPF on thick smear) 11.9% (8/67) 
Gametocyte density range/#l (Counts per 500 WBC on thick smear) 0 - 370 
 
Table 3.2. Blood was sampled from participants who met the clinical case description of cerebral 
malaria during the malaria transmission season in 2011. All patients were from Blantyre, Malawi 
and surrounding areas.  Parasitemia was measured by microscopy and qRT-PCR was performed 
on an RNA sample stored in TriReagent BD. 
 
,&"
Application of the expression-based gametocyte stage prediction process to in vivo malaria 
cohort and in vitro drug perturbation microarray samples 
To gauge how this modeling process performed on patient microarray samples, in 
addition to the more challenging qPCR measurements, we applied it to microarray data from two 
patient cohorts, i) a previously published cohort of severe malaria patients from Blantyre, 
Malawi collected in 2009 [104] and ii) a cohort of uncomplicated malaria patients from Dakar 
and Thies, Senegal collected in 2008.  While no staging information was available for the 
Senegal patients, a subset of Malawi patients were previously identified as gametocyte-positive 
by thick smears. The model inferred that the majority of patients from both cohorts have a strong 
ring-dominated profile, with the next largest subset being late asexual stages (trophozoites and 
schizonts) (Figure 3.5A/B).  For the 10 Malawi samples in which gametocytes were observed by 
thick smear, our model correctly identifies 4 (40%) as such, with 0 false-positive developing or 
mature gametocytes predicted among the 48 thick smear-negative patients (Figure 3.5A). 
Interestingly, two thick smear-negative patients are predicted to have young gametocytes, which 
are difficult to identify by thick smear microscopy due to their morphological similarities with 
asexual stages.  
 
Evaluation of gametocyte carriage in uncomplicated malaria cohort in vivo. A subset of the 
uncomplicated malaria patients from Senegal were also predicted to be gametocyte carriers (6 of 
mature, 1 of developing and 1 of young gametocytes).  As microscopy-based information was 
unavailable for the Senegalese cohort, we assessed how our gametocyte inferences correlated 
with patient parameters. Of the 6 parameters we measured for this cohort, illness duration 
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differed significantly between the group of patients inferred to be gametocyte carriers and those 
inferred to be gametocyte-negative. The former had a longer duration of illness (6.33 days ± 1.02 
SEM) than the latter (3.84 days ± 0.25 SEM, t-test p= 0.0014). This finding agrees with 
published data on clinical correlates of gametocyte carriage: illness duration longer than 2 days 
was found to be a risk factor of gametocytemia in uncomplicated malaria [62].  
 
Evaluation of drug treatment on stage distribution in vitro. We concluded by using the model 
to profile the effects of drug treatments on stage distribution, of particular interest as it was 
recently demonstrated that artemesinin combination therapies (ACTs) have limited efficacy 
against mature gametocytes [42]. For this, we used microarrays from in vitro time course 
experiments with a gametocyte-producing line of P. falciparum (3D7) in which parasites were 
grown in the presence of two experimental antimalarial compounds, Genz-666136 and Genz-
644442. Genz-666136 is known to inhibit the parasite’s dihydroorotate dehydrogenase 
(DHODH) enzyme, which catalyzes the rate-limiting step in de novo pyrimidine biosynthesis.  
Inhibition of DHODH therefore inhibits biosynthesis of DNA, RNA, glycoproteins and 
phospholipids, all of which require pyrimidines [119]. The biological target of the other 
compound, Genz-644442, is unknown. Plasmodium sexual differentiation in response to these 
compounds has not been previously explored.  
 Based on model predictions, mature gametocytes appeared in both drug-treated time 
course experiments at the 20 hours post invasion time point, while in the control experiment, we 
observe an expected progression from ring to trophozoite stage (Figure 3.5C). In both the treated 
and untreated control samples, we predicted an initial, subsequently decreasing fraction of the 
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population to consist of young gametocytes. As these time courses were performed at high 
parasitemia, this distribution is in agreement with what we previously observed for 3D7 at high 
parasitemia (Figure 3.4C).  The presence of mature gametocytes at 20 hours is likely due to a 
differential killing effect of the drug on asexual stages versus mature gametocytes; this would 
induce exactly the inferred increase in the relative proportion of gametocytes.  
 A more complex transcriptional response was provoked during treatment with Genz-
666136, in which an increasing proportion of transcriptional signature could not be assigned to 
one of our stage categories (shown as “unknown”, gray in Figure 3.5C). It is possible that the 
increase in unknown transcriptional signature corresponds to an increase in dying parasites 
across the drug-treated growth experiment.  This proof of concept experiment demonstrates the 
applicability of this assay to examine the impact of various perturbations on asexual and sexual 
stages. 
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Figure 3.5. Application of Microarray Model on malaria patient cohorts and drug 
perturbation time courses. (A). Model inferences for 58 pediatric severe malaria patients 
from Blantyre, Malawi. Stars indicate subjects in 1 or more gametocytes were observed by 
thick smear examination (14 patients). (B). Model inferences for 39 adult uncomplicated 
patient samples from Dakar, Senegal. (C). Model inferences for in vitro time course 
experiments in which samples were taken at 10, 20, 30, and 40 hours post-invasion. Time 
courses were performed in the presence of an antimalarial compound (Genz-666136 or Genz-
644442) or under normal growth conditions (Control). 
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Discussion  
Several highly sensitive single-marker molecular assays are currently used to detect 
Plasmodium gametocytes. None of these existing tools have been appropriate for detection and 
quantification of the full course of gametocyte development; however, due primarily to the lack 
of a sufficiently broad panel of stage-specific markers. Further, since malaria parasite 
populations exist as mixtures of the different phases of the life cycle, assays combining multiple 
markers require customized computational analysis methods for dealing with this complexity. 
We combined the development of such a bioinformatic deconvolution approach with panels of 
stage-specific, intron-containing markers appropriate both for microarray analysis and a newly 
developed qRT-PCR assay. This multi-marker platform enabled us not only to detect gametocyte 
carriers but primarily to infer the relative amounts of sexual and asexual stages within a sample. 
We provide an implementation of this platform for further development and application, 
particularly for refinement in field settings. This process can also be adapted bioinformatically 
by the exclusion or inclusion of markers to answer specific questions, such as determination of 
sex ratios. 
Our deconvolution model provided the opportunity to define stage-specific gene sets and 
to characterize the biology of these stages' expression programs using tools such as GSEA, even 
in the absence of transcriptional data from pure stage populations. For example, our GSEA 
analysis confirms earlier studies that suggested increased mitochondrial and apicoplast activity 
during gametocyte development [82,120]. Interestingly, the analysis also suggests significant 
enrichment of several markers related to endocytic trafficking in late gametocyte development 
but not in any other parasite stage. The biological significance of this observation remains to be 
determined. To put such findings into context and ultimately describe the gametocyte 
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transcriptome at high resolution, a systematic transcriptional re-analysis of the entire P. 
falciparum gametocyte cycle using isolated and synchronous gametocyte stages will be required.  
Transcriptional approaches have significantly increased the sensitivity of gametocyte 
detection in field-compatible assays [49,50,51,57,121]. However, these have been limited to 
either (i) qualitative assessments of multiple gametocyte markers, i.e. RT-PCR of young and 
mature gametocyte markers [57], or (ii) quantitative assessments of mature gametocytes only, i.e. 
QT-NASBA of the gamete surface antigen Pfs25 [49]. In order to properly define the reservoir of 
parasite and gametocyte carriers in the field, it is imperative to determine both the absolute 
parasite burden and the stage composition of parasites in the blood circulation. Challenges have 
prevented the development of a diagnostic that can measure the latter, such as (i) the lack of 
known immature gametocyte markers, and (ii) the lack of transcriptional analysis methods to 
identify gametocytes with high specificity in a sample containing a mixture of stages, and (iii) 
the lack of known intron-containing qRT-PCR compatible gametocyte markers. We therefore 
tackled these challenges by developing a model specific to the quantification process and 
ensuring that it was compatible with both microarray and qRT-PCR measurements. This is 
distinct, of course, from models that would focus only on sensitivity and specificity of 
gametocyte detection from such data, which represent a potentially fruitful course of future 
computational investigation. Instead, by incorporating relative expression values of the markers, 
the model allowed us to both identify a subset of patients as gametocyte carriers and additionally 
quantify sub-categories of immature, developing and mature gametocyte fractions within the 
mixture of stages in bloodstream.  
Following validation of our model on samples for which stage composition was known, 
we applied our model to two microarray data sets in which stage composition was unknown: i) a 
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cohort of uncomplicated malaria patients, and ii) two in vitro growth experiments in the presence 
of drug.  In the former, we found that the mean illness duration of inferred gametocyte carriers 
was significantly higher than that of non-carriers, in agreement with published data 
demonstrating that long illness duration is linked to gametocyte carriage.  In the latter, we 
observed enrichment of mature gametocytes as well as unexplained transcriptional signature 
upon the addition of drug treatment to parasites. These applications demonstrate the range of 
potential uses for this inference tool.  
Both young asexual and sexual mature gametocyte proportions vary over the duration of 
a malaria infection, due to different dynamics with respect to growth and clearance rates 
following antimalarial drug treatment [43,55]. By applying our assay to larger cohorts, we 
anticipate being able to define additional features of the parasite, host or environment that 
influence gametocyte carriage. To be practical in vivo, this will require further refinement of the 
qRT-PCR, field-applicable component of our model. As the exon-exon junction spanning 
primer/probe sets for 5 markers designed here represent the first attempt at a multi-marker 
gametocyte-staged qRT-PCR assay, further modeling of PCR-specific measurement error and 
careful standardization of experimental protocol for this difficult task will both improve field 
inferences. Like the microarray expression model, this model successfully recapitulated the 
transition from asexual to sexual development across multiple in vitro experiments even on first 
application. When used initially in vivo for blood samples from a cohort of children with severe 
malaria in Malawi, the system successfully identified a subset of patients as immature and/or 
mature gametocyte carriers. Because immature gametocytes in particular are present in the body 
approximately one week earlier than the more mature forms, our approach for detecting it could 
be used in further investigations into factors that influence gametocyte conversion in vivo. We 
$-$"
hope that such investigations will be possible in order to further understand and, eventually, 
impede the mechanisms of malaria transmission. 
The assay and algorithm framework presented here has potential for use in 
epidemiological studies such as those of asymptomatic carriers, who likely represent a major 
reservoir for malaria transmission. Multiple such studies are already ongoing and will yield 
additional samples to further optimize computational models of gametocyte differentiation. This 
is also true of data generated from other sensitive expression platforms such as glass-slide arrays 
or Nanostring. The inference process may thus have applications in better understanding the 
natural progression of malaria in the human host, by identifying gametocytes earlier in the course 
of infection and determining the impact of specific drug treatments on gametocyte development. 
By scaling to future population-level screens, the resulting information will help better 
characterize the epidemiology of gametocytemia based on malaria transmission intensity, 
geography, climate and season. 
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CHAPTER FOUR: CONCLUSION 
 
4.1 Gametocyte Sequestration:  Old and New Hypotheses 
4.1.1 Summary of Findings: Sequestration of Gametocytes in the Bone Marrow 
Understanding the basic biology of gametocyte development in the human host can lead to new 
drug targets for processes that are crucial to gametocyte survival in the human host.  In order to 
characterize sequestration sites of gametocytes during their development in the human host, we 
conducted a survey across multiple organs using post-mortem autopsy tissue from cases of 
cerebral malaria.  We observed that across patients, immature gametocytes were found enriched 
in the hematopoietic system in the bone marrow, and lacked morphological characteristics of 
sequestering asexual stages.  These findings have shed light on a previously uncharacterized 
process in the developmental process of the most deadly parasitic disease of humans and suggest 
that gametocytes sequester through a distinct mechanism to that of asexual stages.  These 
findings will open up new avenues in malaria research to determine the exact mechanism 
through which this hematopoietic enrichment occurs, and explore methods to target this 
mechanism for therapeutic strategies. 
4.1.2 Gametocyte Localization in Bone Marrow  
There has been a long-standing hypothesis in the field that gametocytes sequester in the bone 
marrow and the spleen, based on autopsy studies showing an enrichment of immature 
gametocytes at these two sites [9,23]. While these studies were performed in the late 19th and 
early 20th century and lacked the molecular tools or large number of patients used in our current 
study, we confirm their earlier findings, as we also find the bone marrow and spleen to have the 
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highest proportions of gametocytes.  What we add to that early description is new information 
about the localization within the bone marrow, which is a particularly novel finding, as these 
early studies were unable to describe the localization of these stages within the bone marrow or 
the spleen. To date, only one recent case report has demonstrated the presence of gametocytes in 
the extravascular space of the bone marrow [26].  In fact, most research on gametocyte 
sequestration in the past twenty years has focused on identifying receptors for gametocyte 
binding on the surface of endothelial cells, as it was hypothesized that gametocytes bind within 
vessels similar to asexual stages.  Our work supports the notion that gametocytes develop 
exclusively outside of the vasculature within the hematopoietic network of the bone marrow, and 
does not support a model of intravascular binding for developing gametocytes. 
4.1.3 Gametocyte Preference for Erythrocyte Precursor Cells  
Another hypothesis that we examined in our work was the hypothesis of whether gametocytes 
can invade and develop within young erythrocyte precursors. There is evidence to suggest that 
gametocytes may develop at higher rates in reticulocytes and young erythrocytes than they do in 
older red cells. Higher gametocytemias have been reported in patients with high reticulocyte 
counts [122], in mice infected following drug-induced hyper-reticulocyte production [88] and in 
reticulocyte-enriched blood from anemic patients in vitro [87]. These studies however did not 
show direct evidence for the development of gametocytes within these young erythrocytes. We 
show that gametocytes can grow and develop within nucleated erythrocyte precursors in vitro 
and find a subset of gametocytes in erythrocyte precursors in vivo in the bone marrow 
extravascular environment.  
4.1.4 Gametocyte Binding to Endothelial Cells  
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The binding hypothesis is one of the most rigorously examined parts of gametocyte 
sequestration, with a number of studies from different groups exploring the ability of 
gametocytes of various ages to bind to various receptors on endothelial cells [30,31,33,36].  The 
most rigorous of these studies, and the one that showed the highest levels of gametocyte binding, 
was performed using bone marrow endothelial cells [36].  Unlike the studies showing little to no 
binding of gametocytes to asexual receptors CD36 and ICAM-1, this study demonstrated that 
binding of stage III-IV gametocytes occurs to bone marrow endothelial cells and that this 
interaction can be disrupted by incubation with a number of antibodies, thereby identifying 
putative receptors for gametocyte binding.  Importantly they observed that CD36 antibodies 
blocked asexual binding but not gametocyte binding, that ICAM-1 antibodies partially blocked 
binding of both asexuals and sexual stages, and that 3 novel antibodies blocked only sexual 
binding and not asexual binding. The three putative receptors identified through this screen of 47 
antibodies were (i) CD49c or VLA-3 (!3"1), a "1 integrin that is involved in cell-cell and cell-
matrix adhesion interactions in a range of tissues, (ii) CD166 or activated-leukocyte cell 
adhesion molecule, thought to be involved in adhesion of hematopoietic progenitor cells and 
found on bone marrow stroma, and (iii) CD164 or MGC-24, an adhesive glycoprotein found on 
hematopoietic progenitor cells and stroma.  Interestingly, gametocyte binding was not blocked 
by the addition of any one antibody, but reduced by each of these, suggesting a role of multiple 
receptor-ligand interactions or non-specific steric hindrance in gametoycte binding [36]. 
 It is important to revisit these observations in light of our recent characterization of 
gametocyte enrichment in the extravascular space of the bone marrow, often localized at 
erythroblastic island structures.  Erythroblastic islands are the sites within the bone marrow 
where erythroblasts spend their development.  They are characterized by a number of 
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erythroblasts (estimated between 5 and 30), of similar age, surrounding a central macrophage.  
These islands are believed to migrate toward sinusoids as the erythroblasts mature.  Islands are 
maintained through a variety of adhesive interactions between erythrocytes and the nursing 
macrophage, and between erythrocytes.  Three pairs of receptor-ligand pairs have been identified 
in these adhesion interactions: (i) erythroblast macrophage protein (EMP) is found on both the 
erythroblast and macrophage and binds itself, (ii) !4"1 integrin (VLA-4) on erythroblast and 
VCAM-1 on macrophage, and (iii) ICAM-4 on the erythroblasts and !5 integrin on the 
macrophage. Additionally, several macrophage proteins are known to be receptors (though their 
erythroblast partners are unknown).  These include CD69 (sialoadhesin) and CD163.  It is 
unknown how many additional uncharacterized adhesion interactions occur between these cells, 
but it is believed that additional receptors may be involved [86]. 
 Our work demonstrates that binding to erythroblastic islands could be a possible 
adherence mechanism for the immature gametocyte.  As neither a complete set of receptors has 
been identified for either gametocyte binding, nor erythroblastic island composition, it remains 
possible that there is some overlap between the receptors involved in these two processes. For 
example, "1 integrins are involved in both processes (!3"1 involved in binding of gametocyte-
infected erythrocyte, and !4"1involved in binding of erythroblasts to macrophages).   
 These early binding studies should be revisited using erythroblasts and macrophages, to 
test binding of gametocytes in vitro.  This could be achieved by performing rosetting assays with 
these cell types and gametocytes, and/or reconstituting erythroblastic islands in vitro and testing 
gametocyte adherence.  This may be a more representative system to study binding interactions 
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of immature gametocytes inside the bone marrow parenchyma instead of the previously used 
bone marrow endothelial cell lines.   
4.1.5 Gametocytes Detection By Immune System (Or Lack Thereof)  
 It is possible that the immature gametocyte may go completely unrecognized by the host 
immune system during its development.  Whereas parasite-derived ligands localize to the surface 
of the asexual infected erythrocyte in order to mediate adherence and, in so doing, elicits an 
immune response, the surface of immature gametocyte infected erythrocytes appears to lack 
parasite-derived adhesive molecules, and appears to not elicit any immune response. Antibodies 
to KAHRP and PfEMP1 can be found in the serum of individuals who have been exposed to 
malaria, and phagocytosis of asexual-infected erythrocytes is an important mechanism of the 
host to control asexual parasitemia.  Gametocytes have been shown to lack KAHRP and knob 
structures on their surface in vitro [33], and our data confirms the presence of knobless 
gametocytes in vivo.  Further, PfEMP1 was shown to localize within the gametocyte, rather than 
on the surface of the infected cell as it does in asexual-infected erythrocytes [33].  In fact, the 
transport machinery required to export these parasite-derived proteins to the surface of the 
infected erythrocyte has not been described in gametocytes. 
 Immunological studies also suggest the lack of parasite-derived antigens on the surface of 
immature gametocyte-infected erythrocytes. In a study of immune recognition of parasitized 
erythrocytes, using plasma samples from 194 Gambian children, many of whom were shown to 
be gametocyte carriers, not a single sample recognized the surface of an immature gametocyte-
infected erythrocyte.  This was despite mature gametocyte- and schizont-infected erythrocytes 
being recognized by a subset of plasma samples [93].  Further, in phagocytosis assays using 
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monocytes/macropahges and polymorphonuclear neutrophils, gametocyte-infected erythrocytes 
were phagocytosed at very low rates compared with schizont-infected erythrocytes [85].  In our 
study, we also noted that phagocytosis of parasites within the bone marrow affected asexual 
parasites to a higher degree than it did gametocytes.  
 These lines of evidence suggest that the immature gametocyte infected erythrocyte is an 
immunologically unrecognized cell that lacks any parasite-derived ligands on the surface of the 
host erythrocyte.  Since the gametocyte does appear to have some level of binding capacity, this 
raises the possibility that the gametocyte hijacks some host process such as the natural binding 
interactions that occur within erythroblastic islands.  If in fact gametocytes have a preference for 
growth within young erythrocytes, it may be that gametocytes are found exclusively within a 
subset of erythrocytes that still express adhesive surface markers found in erythroid development 
(such as erythroblast macrophage protein, EMP [86]). It remains to be explored whether the 
gametocyte infected erythrocytes bind via host receptors. 
4.1.6 Gametocyte Localization in the Spleen  
 The spleen has been implicated as a possible gametocyte sequestration site based on 
histological work from early autopsy studies [9,23], and more recently through the deformability 
studies of immature gametocytes [38,39,123].  The deformability studies suggest that immature 
gametocyte-infected erythrocytes are unable to cross through sinusoidal slits. These slits are 
designed to filter any defective erythrocytes and thus any rigid parasitized erythrocyte (asexual 
schizont and immature gametocyte-infected cells) would be filtered through the spleen’s normal 
filtration system in the splenic sinuses.  Therefore the hypothesis exists that immature 
gametocytes bind to endothelial cell linings of the splenic sinuses to avoid getting filtered (which 
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would result in their destruction).  However, the lack of binding of gametocytes at high rates to 
endothelial cells would suggest that this may be unlikely.   
 There are two other possibilities for the observation of gametocytes in the spleen.  First, 
the gametocytes found within the spleen could be enriched there due to the large amount of 
circulating blood found in the spleen and the enrichment of mature gametocytes in the 
circulation.  Data from our study does in fact suggest that there is an enrichment of mature 
gametocyte transcript and larger size gametocytes in the spleen.  However, it has been noted in 
the early autopsy studies that immature gametocytes are found in this organ as well (and we also 
note a large size distribution in the spleen in our study).  Therefore, another possible explanation 
is that these immature stages failed to sequester in the bone marrow and thus ended up in the 
spleen, not sequestered, but trapped by the filtration system.  A piece of evidence in support of 
this theory is a case report of a splenectomized individual who had immature gametocytes in 
addition to trophozoites and schizonts present in the circulating bloodstream [124].  Presumably, 
in a spleen-intact individual, the combination of both cytoadherence (parasite succeeding in 
avoiding immune clearance) and splenic filtration (the fate avoided by successfully 
cytoadhering), will result in the absence of immature gametocytes and asexual schizonts from the 
bloodstream.  And the failure rate of cytoadherence is what is observed in the blood of a 
splenectomized patient.  It is not well understood how successful cytoadherence is, i.e. what rate 
of failure we would expect to find in the blood vs. in sequestration, but the large numbers of 
trophozoites and immature gametocytes identified in the splenectomized individual suggest that 
splenic filtration of both of these stages occurs at a high rate during infection. In this case, 
enrichment of immature gametocytes in the spleen could merely be due to the transient 
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appearance of filtered immature gametocytes prior to their destruction and does not necessarily 
equate to this organ being a true enrichment site. 
4.1.7 Gametocytes localization in other tissues  
Our tissue survey revealed the presence of gametocytes in various tissues of the body. While the 
gametocyte percentage was typically low in all organs other than the bone marrow, their 
presence in organs like the brain and gut revealed that gametocytes could form in other sites of 
the human host.  In the blood of anemic patients, higher than normal percentages of reticulocytes 
are found in the circulation.  And if anemia results in body-wide environmental stress cues that 
can induce commitment to sexual development, then it is possible that gametocytes could form 
in other sites than the bone marrow.  However, the fate of these gametocytes is unclear. These 
gametocytes are likely to be present in the circulating bloodstream for a short time before they 
end up in the spleen, filtered due to their rigidity. They may only survive if they get stuck in 
vessels occluded by asexual schizonts (as may be the case in the patients in our study, 
particularly in the organs of high vascular sequestration such as the brain), but in that case, it is 
not clear whether the mature forms can escape and get into the flowing vasculature. 
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4.2 Gametocyte Detection: Old and New Methods 
4.2.1 Summary of Method: Inference of stage proportions based on gene expression data 
We have developed a method for identifying stage-specific markers and inferring developmental 
stage composition based on gene expression.  This has allowed us to successfully infer the 
induction of gametocytes in time course experiments in which parasites were put under stress, as 
well as for the identification of carriers of young and mature gametocytes from cohorts of 
malaria patients.  This framework enabled us to dissect stage-specific transcriptional signatures 
out of mixed stage samples (containing young and mature asexual and sexual stages), which are 
found during the course of malaria infection.  
4.2.2 Application of inference tool for the identification of risk factors for 
gametocytogenesis 
 It has been proposed that early gametocytes may circulate in the peripheral blood for a 
short time prior to their sequestration.  This hypothesis is supported by data showing that 
infected blood containing ring stages when grown ex vivo can produce stage II-III gametocytes in 
three days, indicating that the gametocytes were already present in the blood as very young stage 
I gametocytes or gameto-rings [25]. While our gametocyte sequestration study suggests the 
formation of gametocytes could occur inside the bone marrow within erythrocyte precursor cells, 
we cannot exclude the possibility that gametocytes form in other locations in the body in which a 
gametocyte-committed merozoite comes into contact with an erythrocyte precursor.  While this 
is most likely to occur in the bone marrow as the marrow is enriched with erythrocyte precursors, 
in cases of malaria anemia, higher percentages of reticulocytes are found in the circulating blood 
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than in healthy conditions (normally reticulocytes make up 1% of circulating erythrocytes).  
Thus the possibility still exists, particularly in anemic patients, that some subset of young 
gametocytes form within circulating reticulocytes and initially circulate in the blood stream prior 
to getting filtered out by the spleen.   
 Detection of the these young gametocyte in the peripheral blood is very difficult due to 
its morphological appearance that is indistinguishable from asexual stages.  Molecular markers 
are therefore required to identify these stages.  qT-NASBA using Pfs16, a constitutive marker of 
gametocytes, was initially used in an attempt to quantify the subset of ring parasites that were 
young gametocytes, but due to Pfs16’s background levels of expression in asexual stages, this 
marker was not successful in achieving this goal. 
 Detecting young gametocytes in the blood stream could be potentially useful as a tool for 
identifying risk factors that trigger gametocyte production.  Current methods for assessing risk 
factors for gametocyte carriage involve comparing clinical or environmental factors to the 
presence of mature gametocytes in the peripheral blood.  However, as mature gametocytes 
require 8-10 days to develop, the mature stage is not an ideal marker for determining what 
initially led to conversion toward sexual development.  The detection of young gametocyte could 
enable better associations to be made between risk factors and increased commitment to 
gametocytogenesis. 
 Our qRT-PCR assay and model enabled us to infer the proportion of in vitro and in vivo 
samples that is composed of young gametocytes, and therefore this tool represents the 
opportunity to identify carriers of young gametocytes in patient cohorts.  The tool could be used 
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in parallel to study gametocyte conversion in the laboratory, to assess a shift toward sexual 
conversion following in vitro perturbations thought to induce gametocytogenesis.   
4.2.3 Application of inference tool for the assessment of infection status  
 In addition to inferring proportions of young and mature gametocyte stages in a sample, 
the model also enabled us to look at young and mature asexual stages and undetermined 
fractions.  These too have applicability in field settings. 
 In a typical malaria infection, rings and mature gametocytes are the only stages present in 
the peripheral blood stream.  However, under unusual circumstances, trophozoites and schizonts 
can be observed in the peripheral blood, i.e. directly following drug treatment, or in cases of 
severe infection [118].  One possible application of the prediction of ring and schizont 
proportions could be for the measurement of blood schizontaemia, a sign of severe disease, and 
thus could be potentially useful for clinical reasons.  
 During an in vitro time course in which parasites were grown in the presence of drug, we 
noted an increase in the proportion of unexpected signal that could not be assigned to a known 
stage.  While we have yet to fully understand the reasons for this observation, we recognize that 
the prediction of large fractions of unexpected signal could be useful in examining perturbation 
data. Certain antimalarials are known to slowly kill parasites, or even induce a dormant stage in 
which parasites are alive but remain stuck in the ring stage and do not progress normally through 
development until release of drug pressure.  A careful study of the stage distributions produced 
by a panel of antimalarial drug perturbations could for instance provide information on what the 
‘fingerprint’ of a cytostatic vs cytotoxic drug looks like.  We could hypothesize for example that 
the stage distribution would halt in place for a cytostatic drug, versus show increased levels of 
$$'"
unexplained signal for a cytotoxic drug.  The applicability of this tool for understanding the 
affect of antimalarial drugs on stage dynamics has yet to be fully explored, but this tool could 
potentially be useful in either in vitro or clinical settings to track the efficacy of particular drug 
treatments. 
 Further, some drugs have been hypothesized to induce the formation of gametocytes, 
while others have been hypothesized to selectively kill asexuals while leaving gametocytes 
unaffected.  The stage inference model could be used to test how antimalarial drugs affect 
gametocyte production.  The stage-specific determination of young vs. mature gametocytes 
would enable the differentiation between drugs that induce conversion versus those that select 
for older gametocytes that were already present prior to drug treatment. 
 
4.2.4 Future applications for this framework: inferring infectivity from gene expression 
 As molecular methods have dramatically increased the sensitivity of mature gametocyte 
detection from thick smear microscopy-based assessments, higher rates of mature gametocyte 
carriage have recently observed in patient cohorts.  The mere presence of mature gametocytes in 
the blood stream does not necessarily equate to transmissibility.  Thus, more refined biomarkers 
of gametocyte infectivity are required to obtain a useful measurement of one’s transmission 
potential.   
 Our framework could be applied to different kinds of gene expression-based inferences to 
achieve this goal.  For example, the proportion of male and female gametocytes (both of which 
are required for successful transmission) could be inferred based on expression of male- and 
$$("
female-specific genes.  These markers could then be used in a qRT-PCR assay and could provide 
a way to grade infections based on infectiousness. 
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APPENDIX A 
 
 
 
Appendix Figure A1. Representative pLDH and Pfs16 labeling across tissues. (A). pLDH. 
pLDH-labeled parasites were identified in all the 9 tissue types analyzed. In a subset of those 
tissue (i.e., brain, gut and heart) the classically described pathology of packed vessels was 
observed. (B). Pfs16. Pfs16-labeled parasites were observed in multiple tissues including those 
previously reported with gametocytes (i.e., bone marrow and spleen).  
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Appendix Figure A2. Stage Specificity of antibodies by IHC. Gametocytes were induced 
according an established in vitro gametocye induction protocol [74], with Day 0 being the first 
day of gametocyte development. Infected RBCs from the time course were mixed with surgical 
tissues fixed in formalin and embedded in paraffin (FFPE) to be used for optimization and 
positive controls in subsequent experiments. (A). Images of parasites labeled with either 
pLDH or Pfs16. Representative images of IHC with pLDH and Pfs16 on in vitro control tissue 
blocks are shown from Day 0 and Day 7. (B). Quantification of antibody labeling across 
gametocyte development. The average number of Fast Red-positives observed in 5 high power 
fields (HPFs) is shown. As expected, Pfs16 labeling is present at Day 7 of gametocyte 
development but not at Day 0 (where parasites are still at ring stage). Of note, given the 1:5000 
antibody titration used, we did not observe Pfs16 labeling in Day -1 (committed schizonts) or 
Day 0 (gametocyte ring). We began seeing Pfs16 staining at Day 2 of small oat-shaped stage I 
gametocytes.  
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Appendix Figure A3. Morphology of gametocyte stages by immunohistochemistry. Shown 
are in vitro cultured infected RBCs from the gametocyte induction protocol used to generate 
RNA and IHC control samples.  Stage distribution in each sample was determined using 
methanol fixed smears followed by Wright’s Giemsa stain. Images of stages I-V, as determined 
by morphology, are shown from the Giemsa stain.  Based on known distributions of stages, 
images of gametocytes in each stage were imaged from the FFPE control block (containing in 
vitro cultured gametocytes from the same daily time points as the Giemsa stained slides).  These 
were taken following IHC using mouse Pfs16 antibodies with AP-Fast Red.  Images were then 
processed in ImageJ using the particle analysis function.  Measurements of area in square micron 
and length in micron are shown for the range of gametocytes imaged for that stage.  For each 
stage, we had at least five measurements.  Shown is the median (and range). 
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Appendix Figure A4. Development of qRT-PCR assay. (A). Primer efficiency. Each 
amplicon was inserted into a pGEM-T easy plasmid and curves generated using serial dilutions 
of plasmid DNA (see Appendix Table A1 for primers). (B). Gametocyte time course and 
staging. Gametocytes were induced according to Fivelman et al [74] and samples collected every 
day for 10 days. Parasites were labeled with nuclear dye DAPI and gametocytes were stained 
with antibodies against the gametocyte marker Pfs16. Gametocytes were identified based on 
Pfs16-labeling and categorized into the five known stages I-V, according to Sinden et al [29]. 
(C). Representative images from the time course experiments. Shown are early, mid stage 
and late gametocytes, labeled with Pfs16 antibody and DAPI. (D). Stage-specific expression of 
markers. While UCE shows relatively constitutive expression, the gametocyte markers increase 
upon induction according to their known expression peaks: PF14_0748 peaks at days 3 and 4, 
Pfs48/45 peaks at days 7-9 and Pfs25 peaks at days 9 and 10. 
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Appendix Figure A5. RNA quality from brain and bone marrow tissue samples. (A). RNA 
size distribution per sample. Purified and DNAse digested RNA from 6 brain (BR) and 6 bone 
marrow samples (BM) was run on a Bioanalyzer to determine the length distribution of RNA 
fragments. The most prominent bands are human 28s and 18s rRNA bands (at app 4000 and 
2000nt, respectively, see arrows). (B). RIN and PMI. Based on the average RNA integrity 
number (RIN, a measure for the average RNA fragment length), the RNA in these tissues is 
considered partially degraded but sufficient for the small fragments (100 - 200 nt) amplified by 
the qRT-PCR assay. A positive correlation is observed between the RIN and post mortem 
intervals (PMI, the time between death and autopsy), suggesting that RNA degrades more with 
increased PMI. In addition RNA from brain samples appears generally more degraded than from 
bone marrow samples.  
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Appendix Table A1. Primers used in this study for the qRT-PCR assay.    
 
Name Accession  Stage-Specificity 
Primer 
Efficiency Primer sequence (listed 5’ to 3’) 
Plasmodium 
exported protein 
(PHISTa) 
PF14_0748 early - mid gametocyte 97.6% 
ATTCAAGGGTAGTTCCTAGAGCAGTGTGG 
AGCACTCGTAATTCTAACACTGGG 
6-cysteine protein 
(Pfs48/45) PF13_0247 
mid - late 
gametocyte 101.4% 
GTAAGCCTAGCTCTTTGA ATAGTGA 
GACCTACGTTCACGCATATCTGGCT 
25 kDa ookinete 
surface antigen 
precursor 
PF10_0303 late gametocyte 93.1% GGA AATCCCGTTTCATACGCTTGT TCTTGTACATTGGGAACTTTGCCT 
Ubiquitin-
conjugating enzyme PF08_0085 all stages 100.5% 
GGTGTTAGTGGCTCACCAATAGGA 
GTACCACCTTCCCATGGAGTATCA 
Table SX. Primer pairs used in qRT-PCR assay. 
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APPENDIX B 
 
 
 
Appendix Figure B1. Performance of the 5 marker model on published microarray data 
sets. (A). Actual and (B) inferred stage distributions across five microarray time courses (two 
asexual and three sexual) with reference stage distributions determined by microscopy. Five 
markers were used to make these predictions (Table1). (C). Bootstrap cross-validation of error 
rates expected per-stage in model inferences. Violin plots show expected density, with internal 
boxplots detailing the 25th -75 th  percentiles and 1.5x fences. 
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Appendix Figure B2. Application of the model on microarray data from previously 
analyzed patient samples. Re-analysis of an uncomplicated patient cohort collected in Senegal 
between 2004 - 2006, and published in [80]. Proportions of total parasitemia as inferred by 
modeling of parasite transcriptional activity in patients are shown here, as measured by 
hybridization on Affymetrix chip. As expected, most uncomplicated patients are dominated by 
asexual ring stages, with minorities in both groups transitioning to trophozoites. 
Disproportionately large fractions of gametocytes and uncharacterized stages enriched in the 
Cluster 1 patients. 
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Appendix Figure B3. qRT-PCR Assay Optimization. (A). Efficiency of qRT-PCR reactions 
using 10-fold dilutions of mixed parasite cDNA. 4 to 6 dilutions were assessed for each primer, 
and efficiencies were in the acceptable range for all 5 primers (87-92%). R2-values were all 
greater than 0.96. Technical variation between replicates was very low: the average standard 
deviation between technical replicates was 0.243 and ranged between 0.01 and 1.543. (B). Stage-
specificity of qRT-PCR markers. Using two clones of 3D7, F12 (gametocyte deficient) and wild 
type (gametocyte producer), we performed in vitro gametocyte inductions and collected samples 
at days -1, 0, 1, 5, 10 according to the Fivelman et al protocol [74] and collected RNA. Results, 
displayed as relative expression normalized to constitutively expressed marker PF11_0209, 
confirm stage-specificity of markers. Giemsa images of representative parasite stages observed at 
each time point of the wild type 3D7 time course are shown above the graphs 
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[TableB1.xlsx] 
Appendix Table B1: Annotated Gene List and Metadata. Annotations of the 5160 genes in 
the P. falciparum transcriptome used in the analysis, including the frequency of selection in our 
subsampling and backward selection steps, presence of an intron, contribution of expression to 
stage, determination of stage specificity, product description and population genetic parameters 
of total SNP counts, diversity and divergence. 
 
[TableB2.xlsx] 
Appendix Table B2: Complete GSEA Results per Stage. Results for each stage in our 
microarray model, wherein the per gene z-scored contributions of expression to that stage were 
ranked and were characterized for enrichment in functional pathways.  
 
[TableB3.xlsx] 
Appendix Table B3: GSEA Gene Sets. Gold Standard Catalog of GO and Kegg pathways 
obtained from individual GO slims from PlasmoDB and the GO ontology integrated into the GO 
hierarchical structure. 
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Appendix Table B4. Sequences for primers and probe used in qRT-PCR assay. 
PFE0065w (ring) 
Reverse:  TTGCTAGGTAATATCCTTTTCTTTTTCC 
Forward:  GCAAAACAAGCCGTACATGTTG 
Probe:   6FAM - TTG TTC ATC AAC TTT TAC AAC TT - MGBNFQ 
 
PF10_0020 (troph/schizont) 
Reverse:  GACGTTTGATTTGTTTCCTGTTTTATC 
Forward:  GGAATGATTTATTTGTTAATTAAAGATGTTG 
Probe:   6FAM - ACG AGG AAA TTA GCT GAA GC - MGBNFQ 
 
PF14_0748 (early-mid gametocytes) 
Reverse:  TTGGCCACACTGCTCTAGGA 
Forward:  CTTATGTGCTGAATTTTGTGTTATGGT 
Probe:   VIC - CAC ATA ATG AAT TCA AGG GTA G - MGBNFQ 
 
PF14_0367 (mid-late gametocytes) 
Reverse:  TCCCTGTGTTTTTGCTCATCTTC 
Forward:  GTTACATTTCGACCCAGCATAAATT 
Probe:   VIC - CAG TGC ATA TTG TTG CCT GT - MGBNFQ 
 
PF11_0209 (all stages) 
Reverse:  CATAATGCTACTAACTACTAATATGCAAAAATATACC 
Forward:  CGCTAGAATTACATGGAGACAAATCA 
Probe:   VIC - AAA AGG TCA AGC CTT CAT T - MGBNFQ 
$'$"
Appendix Table B5. Additional qRT-PCR Assay Optimization Data.  
Gene Stage-Specificity 
Pf cDNA 
(mixed stage) Pf DNA Human cDNA Human DNA H2O 
All reactions run to 45 
cycles. Probe SYBR Probe SYBR Probe SYBR Probe SYBR Probe SYBR 
PFE0065w ring 20.173 15.849 - 39.713 - - - 42.893 - - 
PF10_0020 trophozoite/ schizont 30.502 25.823 - 44.637 - - - - - - 
PF14_0748 early - mid gametocyte 32.287 27.037 - 40.020 - - - - - - 
PF14_0367 mid - late gametocyte 33.313 29.075 - 40.950 - - - - - - 
PF11_0209 all stages 27.530 22.576 - - - - - - - - 
 
Appendix Table B5. Primers were specifically designed to cross exon-exon junctions, so as to 
reduce genomic DNA amplification, and were checked for homology against Plasmodium or 
human homologous sequences using PlasmoDB and NCBI Blast in order to eliminate the 
chances of non-specific amplification. Using our primer set with sequence-specific probes 
showed no cross-reactivity with genomic DNA or human templates. Our primer sets also greatly 
reduced the amount of genomic DNA amplification even using SYBR (CT>39 as compared with 
DNA-amplifying control marker at CT = 25), yet it was not zero.   
 
 
